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ABSTRACT
Post-synthesis DNA modification is a very useful method for DNA functionalization.
This is achieved by using a modified NTP, which has a handle for further modifications,
replacing the corresponding natural NTP in polymerase-catalyzed DNA synthesis. Subsequently,
the handle can be used for further functionalization, preferably through a very fast reaction.
Herein we describe polymerase-mediated incorporation of trans-cyclooctene modified thymidine
triphosphate (TCO-TTP). Subsequently, the trans-cyclooctene group was reacted with a tetrazine
tethered to other functional groups through a very fast click reaction. The utility of this DNA
functionalization method was demonstrated with the incorporation of a boronic acid group and a
fluorophore. The same approach was also successfully used in modifying a known aptamer for

fluorescent labeling applications. Boronic acid modified DNA molecules were further applied in
aptamer selection for cancer cell recognition.
The second project was focused on developing fluorescent probes/sensors for biothiols.
Because of the biological relevance of thiols and sulfides such as cysteine, homocysteine and
hydrogen sulfide, their detection has attracted a great deal of research interest. Fluorescent
probes are emerging as a new strategy for thiol and hydrogen sulfide analysis due to their high
sensitivity, low cost, and ability to detect and image thiols in biological samples. A sulfonyl
azide-based fluorescent probe has been developed for the quantitative detection of H2S in
aqueous media such as phosphate buffer and bovine serum. In addition, another novel
fluorescent probe has been developed for the detection of homocysteine. The fluorescence
response is selective for homocysteine over other biologically abundant thiols such as cysteine
and glutathione. In addition, a linear calibration curve was also be obtained for quantitative
analysis in phosphate buffer and plasma. These selective fluorescent probes could be very useful
tool for biothiol tests.

INDEX WORDS: Post-synthesis modification, Bioorthogonal reaction, Oligonucleotides,
Gasotransmitter, Biothiol detection, Redox reaction
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1

DEVELOPMENT OF BORONIC ACID-MODIFIED NUCLEOSIDE
TRIPHOSPHATE FOR DIAGNOSTIC APPLICATIONS

1.1

Introduction
1.1.1

DNA modification methods

Beyond its natural functions as genetic codes, the utility of DNA in sensing,1-2 new
structural scaffolds,3 therapeutics,4-6 and in vitro aptamer selections7-9 have been wellestablished. As such, modified DNA molecules are often used because of the possibility of
endowing additional structural and spectroscopic properties, which allow for enhanced functions
and detection.10-11 Thus DNA modification has been a very active field of research; and several
excellent results on DNA modification methods and applications by were reviewed.12-14
As a historical background, using modified nucleosides for biological incorporation and
their various applications are far from a new thing, although recent interest levels are very high.
Tritiated ([3H]) thymidine autoradiography was firstly introduced in the late 1950’s and served as
a powerful technique for studying cell proliferation in situ for decades.15-19 Later, less timeconsuming strategies that do not rely on radioactive materials were developed to study cell
proliferation and neurogenesis.19 For example, many halogenated thymidine analogs such as
BrdU, CldU, or IdU (Figure 1.1)

19-20

were developed as alternative labeling methods. BrdU is

currently the most commonly used metabolic label and has been widely used in areas such as cell
proliferation and neurogenesis.19, 21-22 In such an application, an antibody against BrdU is used to
detect incorporation levels. However, harsh chemical denaturation conditions needed for
processing the cellular DNA and poor tissue penetration of the BrdU antibody limit the utility of
BrdU.23 Especially important is the fact that these methods do not allow for studying live cells.
In order to overcome limitations of existing methods, new chemistry is being developed. Such

2

new chemical strategies are bio-orthogonal, have a diverse set of structural properties for various
applications, and allow for exploration of DNA in their native environments.24-32 Often these
newer approaches involve the use of click chemistry.33-34

Figure 1.1 Structures of BrdU, CldU and IdU

In 2006, Seela35 and Carell36 firstly reported modifications of deoxynucleotides through
copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction developed by Sharpless37 and
Maldel.38 In the earlier cases, only a small modification such as an azide or a terminal alkyne is
initially introduced, to make sure the structure and function of the biomolecules remain virtually
unchanged.24-25 Later on, copper-free click chemistry was widely used in chemical biology
applications,39-41 in order to avoid issues related to copper.42 Especially in DNA modification,
several pieces of recent work including crossing-linking,43-44 biomolecules labeling,45-49 and
cellular imaging50 have been published in this area. Different types of “clickable” analogues have
been used for visualizing DNA synthesis through secondary functionalization via click
chemistry. In such an approach, a synthetic label containing a bio-orthogonal functional group is
metabolically incorporated into the cellular target and subsequently probed using a
chemoselective reaction.
Among all the nucleoside/tide modifications, which still allow for enzymatic recognition,
modified thymidine analogs are probably the most commonly used. It has long been known that
modification at the C5-position of deoxyuridine can be tolerated by various polymerases.51-52 In
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addition to examples of modified nucleosides being incorporated into DNA in live cells; there
have also been interests in developing modified nucleosides/tides for direct incorporation into
DNA in enzymatic reactions. In such an approach the triphosphorylated nucleosides are needed
for polymerase-mediated DNA synthesis. The modified residues have to be recognized by
polymerase and also be stable under primer extension and PCR conditions. An often-used
strategy is to first modify the nucleoside with a handle that (1) is tolerated by DNA polymerases
and (2) can be used to introduce additional functional groups after DNA synthesis.14, 53-54
There are several publications reported strain-promoted alkyne–azide cycloaddition
(SPAAC) reaction being applied in nucleic acids labeling55-56 and DNA ligation.57 The Brown
group reported ligation work57 and DNA cross-linking using dibenzocyclooctyne (DIBO) and
bicyclo [6.1.0] non-4-yne (BCN) modified phosphoramidite for chemical synthesis of modified
DNA.58 Recently, the same group reported successful enzymatic incorporation and labeling
using DIBO and BCN modified triphosphates through primer extension (Figure 1.2).59

Figure 1.2 Structures of BCN and DIBO modified TTP

In addition to the C5-position of deoxyuridine, the C8-position of deoxyguanosine is
another common site for DNA modification.60 Earlier work was focused on chemical synthesis
and applications in studying oligonucleotides’ conformation and investigating DNA
hybridization.61-63 In 2012, Diederichsen and coworkers firstly developed a chemically
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synthesized fluorescent 8-vinyl-2’-deoxyguanosine (VdGTP, Figure 1.3, compound 6) modified
DNA for topology exploration.64-65 Enzymatic synthesis of VdGTP-modified DNA was also
reported in the same year.66 There are other 8-styryl-2’-deoxyguanosine (SdGTP, Figure 1.3,
compound 7) modified DNA reported, which focuses on its unique photochemically reversible
isomerization potential.67 Experiments showed that these guanosine derivatives had no or
minimal effect on the B-form structure of DNA.

Figure 1.3 Structures of modified GTP

Among the different modification sites of nucleosides, deoxyadenine modification and
enzymatic fluorescent labeling were also examined. As discussed above, inverse electron
demand Diels–Alder (IEDDA) has been applied in DNA modifications because of its reaction
rate and bio-compatibly. Marx and co-worker reported vinyl-modified DNA and its labeling
using IEDDA in 2014.68 7-vinyl-7-deaza-2’-deoxyadenosine (dvinA) and 5-vinyl-2’-deoxyuridine
(dvinU) were synthesized following a known procedure69 for further enzymatic incorporation and
post-synthesis labeling.
Hocek’s group reported a fluorophore-labeled nucleotide, dNAPI (or DAPI)TP (Figure 1.4,
compound 8, 9)70 for DNA-protein interaction studies in 2012. In further studies of DNA-protein
interaction using fluorophore-labeled DNA molecules, Hocek and co-workers designed and
synthesized

a

GFP-like

fluorophore-labeled

DNA.71

Specifically,

4-hydroxy-

benzylideneimidazolinone (HBI) is a fluorophore in GFP,72-73 which shows weak fluorescence as
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a free molecule form in denatured protein.74 The fluorescence of HBI can be significantly
increased by restricting its conformational freedom, as is in the situation of binding to a
protein.75 Developed from previous reported work on HBI linked with RNA,75 3,5-difluoro-4hydroxybenzylideneimidazolinone (FBI) and 3,5-bis(methoxy)-4-hydroxybenzylideneimidazolinone (MBI) were conjugated with cytosine triphosphate (CTP) to label DNA molecules (Figure
1.4, compound 10, 11).71

Figure 1.4 Structures of (D)API and M/FBI modified CTP

From the examples above, it is clear that modifications on the nucleobase of
deoxynucleoside triphosphates allow for the creation of very useful probes in studying DNA
replication and binding with proteins. Conceivably, sugar modifications represent possibilities.
However, the deoxyribose portion does not have many positions that allow for modification
without fundamentally changing its properties. The only position, which might allow for the
modification with halogenation such as “fluorination” and the introduction of a protected
hydroxyl group, is the 2’-position. Those with a free 2’-hydroxy group have similar structures
with RNA monomers, and are hardly recognized by DNA polymerase.76 In 2009, Wagenknecht
and coworkers reported the chemical synthesis of sugar modification site on 2’-O position of
ribose.77 In 2013, the same group reported enzymatic synthesis and fluorescent labeling of 2’-Opropargyl-TTP.78 This RNA-type 2’-O-propargyl nucleoside triphosphate (pNTP, Figure 1.5,
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compound 12) is recognized by DNA polymerase and forms duplex structures with its
complementary sequences.

Figure 1.5 Structure of pNTP

There have been other sites modifications, like backbone modifications that use chemical
synthesis instead of enzymatic incorporations.79-80 They will be very useful as well. In addition to
enzymatic incorporation of modified nucleotides into DNA, a number of chemical syntheses of
modified DNA have been published. For example, Wagenknecht’s group published work on
post-synthetic fluorophore labeling using copper-free click81 and photoclick reactions.82
Diederichsen and coworkers have developed a fluorescent DNA probe, 8-vinyl-2’deoxyguanosine, and applied it in DNA structural studies64 and peptide nucleic acid (PNA)
building blocks.65 Such work has been reviewed recently, and thus is not discussed in detail.12, 14,
53-54

Aptamers are mostly single strands of oligonucleotides capable of binding to the intended
targets7-9 from small molecules to living cells with high affinity and specificity.83-84 It have been
recognized as useful tools in developing diagnostic and therapeutic agents.85-86 Their diverse
three-dimensional structures provide the possibility for developing aptamer-based molecular
probes that are able to recognize biomarkers of great clinical diagnostic value.87 In recent years,
cell-based systematic evolution of ligands by exponential enrichment (cell-SELEX) has been
extensively used to select aptamer candidates, which can distinguish the cell type of interest, or
recognize the biomarkers of interest on cell surface.88-91 The aptamer candidates go through
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partitioning and will be remained on the target cell due to their higher binding affinity to the
target. The surviving candidates can be collected and amplified by PCR and further go through
several rounds of partitioning. Thus, the sequences with high binding affinity are enriched in the
process of SELEX. However, the cell-SELEX method is usually involving a number of
cumbersome steps and lack of efficiency. Usually, aptamers can be selected from all natural
DNA/RNA pool. However, modifications with appropriate functional groups could endow these
aptamers with special properties for enhanced affinity and/or selectivity. Recently,
Krishnakumar’s group reported an aptamer with fluorophore modification, which can recognize
epithelial cell adhesion molecule (EpCAM).92 Specifically, the EpCAM aptamer sequence
SYL3C93 with a terminal azido group can be conjugated to Alexa-fluor 594 (AF594) with a
DIBO handle. Such modified aptamer was used in cell labeling studies. Flow cytometry analysis
demonstrated successful labeling and obvious fluorescence improvement. Further live cell
incubation and imaging was conducted using MCF7 (high EpCAM expression), Weri-RB1
(moderate EpCAM expression) and MIO-M1 (low EpCAM expression) cells. The aptamer
fluorescence can be visualized and measured by fluorescent microscopy and flow cytometry. The
mean fluorescence intensity (MFI) of the total population correlated with different cell line
EpCAM expression. Cytotoxicity of EpDNA-DIBO-AF594 was also explored with various cells.
No significant toxicity was observed at 1 µM after 48 h incubation. This is yet another example
of the usefulness of DNA modification.
1.1.2

Boronic acid-based chemosensors and applications in DNA modification
Boronic acid is known as one of the most common moieties in chemosensors design

because of its affinity for diols,94-101 α-hydroxyl acids,102-103 α-aminoacids,104 aminoalcohols,105106

alcohols,107-109 even cyanide110-111 and fluoride.112-113 Especially after Czarnik114 and
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Shinkai115 reported using boronic acids as chemosensors for diols in early 1990s’ (Scheme 1.1),
the boronic acid group has been widely used as the building blocks of chemosensors targeting
saccharides,95,

114, 116-120

carbohydrate transporters121-127 and affinitive ligands for affinity

chromatography.128-130 Our group has been interested in using the boronic acid moiety for
sensing applications, especially for carbohydrates chemosensors.97, 101, 118-120, 131-137

Scheme 1.1 Binding equilibrium of phenylboronic acid with a diol

Our group has had a long-standing interest in using the boronic acid moiety for various
sensing applications.97, 131-132, 138 Along this line, we have been working on the incorporation of
the boronic acid functional group into DNA for aptamer selection139-140 and other
applications.141-144 In incorporating the boronic acid group into DNA, there are special
considerations because of the hygroscopic properties and Lewis acidity of this functional group.
We have recently demonstrated the feasibility of direct PCR incorporation of boronic acidmodified TTP (Scheme 1.2, Route A)139 and post-PCR incorporation of the boronic acid group
into DNA (Scheme 1.2, Routes B).142, 144 In post PCR DNA modification work, it is critical that
the reaction goes to completion within a short period of time for various practical reasons. Thus
it would be desirable to use click reactions that are fast enough so that completion of the reaction
is assured on the scale of minutes. With most of the DNA click-modification reactions reported,
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one fast condensation reaction of 1, 2-aminothiol with 2-cyanobenzothiazole (CBT) has a
second-order rate constant of 22 M-1·s-1.48, 144 This means that at 1 µM, the reaction’s first halflife (t1/2) would be more than 12 h. One would have to force the reaction by increasing the
concentration of the non-DNA click partner agent because the concentrations of the DNA
product from PCR amplifications are limited by PCR efficiency at high concentrations and
primer concentrations, and are generally in the low µM range. Even under forcing conditions, it
would still take hours for the reaction to go to completion. Thus, we set out to develop
modification chemistry, which would give a shorter half-life. Tetrazine-trans-cyclooctene
cycloaddition is recognized as one of the fastest click reactions, with second-order rate constant
being up to 22000 M-1·s-1, which would give a first half-life of 45 second at 1 µM
concentration.40, 141, 145-147 Thus in this study, we examined the feasibility of using the tetrazinetrans-cyclooctene chemistry for the post-PCR labeling of DNA with the boronic acid moiety
(Route C, Scheme 1.2).
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Scheme 1.2 A schematic representation of strategies for DNA modifications with a boronic acid

A). Enzymatic incorporation of boronic acid-modified nucleotides; B). Enzymatic incorporation
of CBT modified nucleotides, followed by post-PCR modification; C). Enzymatic incorporation
of trans-cyclooctene modified nucleotides, followed by Cu-free post-PCR modification
1.1.3

Cell-based SELEX
Following the research on TCO-TTP incorporation into DNA molecules and subsequent

boronic acid labeling, we preceded with cell-based SELEX to select aptamers targeting
glycoproteins on the cell surface. We developed boronic acid-modified aptamers that target
mucin 13 (MUC13), a transmembrane glycoprotein expressed in a variety of epithelial
carcinomas. Mucin proteins are known for its protection and lubrication effect on the epithelial
surfaces.148 Mucin 13, a transmembrane type of mucin, has been implicated in cancer
development based on laboratory findings of a malignant phenotype of MUC13-transfected cell
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lines.149-150 Thus, mucin 13 is a potential early marker of epithelial cancer and a promising target
for anti-cancer drug delivery. In this study, we used HPAF II, a pancreatic cancer cell line that
highly expresses MUC13 as our selection target in the cell-SELEX. Another pancreatic cancer
MUC13-null cell line, MIA Paca, was used as a control cell line in the selection process.
1.2
1.2.1

Results and discussion
Synthesis of TCO-TTP
It has long been demonstrated that modification at the C5-position of deoxyuridine can be

tolerated by various polymerases and such modified nucleotide triphosphates can be incorporated
as a thymidine surrogate into DNA.51-52 Thus we chose to install a click handle at the C5position of deoxyuridine for further modifications. The trans-cyclooctene moiety can be
introduced into compound 21 using amidation chemistry.151 Then subsequent triphosphorylation
followed a one-pot three-step method152 to generate the final compound trans-cyclooctene
triphosphate (6) in 32 % yield (Scheme 1.3).
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Scheme 1.3 Synthesis of trans-cyclooctene-modified deoxyuridine/thymidine triphosphate

1.2.2

Thermo-stability Studies of trans-Cyclooctene
Before PCR incorporation studies, we examined the stability of trans-cyclooctene

modified nucleotide at high temperature using NMR and HPLC. To investigate transcyclooctene stability at high temperature, trans-cyclooctene sample was dissolved and heated in
DMSO-d6 at 90 oC. NMR spectra were scanned and recorded every 10 min to observe the
isomerization from trans-isomer to cis-isomer. Isomerization percentage was calculated based on
peak area of the peak at δ 5.55 ppm. Compared to the cis-cycloocetene peak, only 2% and 10%
of trans-cyclooctene changed to the cis-isomer after heating at 90 oC for 20 min and 70 min
(Figure 1.6). In addition to the NMR studies, TCO thermo-stability was further examined with
HPLC. As shown in Figure 1.7, there was no noticeable difference after heating the TCO at 90
o

C for 20 min (Figure 1.7C). After heating at 90 oC for 70 min, almost 20% of TCO underwent
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isomerizzation to giive the cis-iisomer (Figgure 1.7D). Thus transs-cyclooctenne is generaally stable
under PCR conditioons, which nnormally takke 30 cycless (denaturinng at 90 oC for
f 20 s eachh cycle) to
complette the PCR sstep and woould subject the sample to 90 oC forr no more thhan 15 min.

F
Figure 1.6 NMR study of thermo-staability of traans-cycloocteene

Figu
ure 1.7 HPLC
C studies off the thermo--stability of trans-cycloooctene.

A). Bacckground, A
ACN+ 1%DM
MSO; B). T
TCO dissolvved in ACN;; C). TCO hheated at 90 oC for 20
miin; D). TCO
O heated at 990 oC for 700 min
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1.2.3

Enzymatic incorporation and post-synthesis labeling of TCO-TTP
To study whether the modified nucleotide 28 can be recognized by a polymerase, we first

incorporated trans-cyclooctene thymidine triphosphate (TCO-TTP) into a short DNA via primer
extension using the Klenow fragment-catalyzed reaction. Based on previous successful
incorporation studies,141, 144 we used a 21-mer oligonucleotide (nt) template-1 (5’-GGT TCC
ACC AGC AAC CCG CTA-3’), a 14-mer primer (5’-TAG CGG GTT GCT GG-3’) for the
primer extension work (See experimental section for details). The template and primer were
designed in such a way that the first incorporated nucleotide would be a T. Thus if TCO-TTP
cannot be successfully recognized by the polymerase, there would be no primer extension. The
extension products were examined by polyacrylamide gel electrophoresis (PAGE) (Figure 1.8).
The experiments included several negative controls: (1) primer extension with all the necessary
components except TTP (Lane 1, Figure 1.8A) (This is to make sure that enzyme fidelity would
not be an issue and mis-matched incorporation does not happen), (2) primer extension with all
the necessary components except the enzyme (Lane 2, Figure 1.8A), (3) primer extension only in
the presence of the template and primer without the dNTPs and the enzyme (Lane 3, Figure
1.8A), and (4) primer only without the other necessary components (enzyme, template, and
dNTPs) (Lane 4, Figure 1.8A). Positive control was Klenow fragment catalyzed primer
extension using natural dNTPs (Lane 5, Figure 1.8A). TCO-TTP incorporation product was
studied under Klenow fragment catalysis (Lane 6, Figure 1.8A). , It is clear that primer extension
with all natural dNTPs (Lane 5) and TCO-TTP (Lane 6) showed similar full-length double
stranded DNA bands, demonstrating successful incorporation of TCO-TTP. Next, we wanted to
explore the feasibility of post-PCR modification with the incorporation of a boronic acid. Thus,
tetrazine-bisboronic acid (Tz-BBA, Figure 1.8C) was synthesized for click-modification of the
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DNA prroduct. In ddoing the m
modificationn work, we ran the reaaction for 115 min. As shown in
Figure 11B, similar full-length 21-bp DNA
A bands were observedd from prim
mer extension reaction
(Figure 1.8B) using natural dN
NTPs (Lane 1), TCO--TTP (Lane 2), TCO-T
TTP labeledd with TzLane 3), andd dNTP prim
mer extensioon product rreacting witth Tz-BBA (Lane 4). T
There were
BBA (L
some mobility
m
diffferences am
mong Lanes 1-3 with thhe click prodduct (Lane 3) having tthe lowest
mobilityy indicatingg increased molecular weight andd the preseence of the boronic accid group,
which iss a Lewis aacid and cann put a drag on mobilityy. Howeverr, the differeence was sm
mall. Thus
we sougght additionaal evidence in support of
o successfuul incorporaation of TCO
O-TTP and ssuccessful
click moodification.

Figure 1..8 Primer exxtension and
d post-syntheesis boronic acid labelin
ng using TCO
O-TTP.

A). Prim
mer extenssion using dNTP or TCO-TTP replacing TTP
T
catalyyzed by thee Klenow
fragmennt, 20% PA
AGE analysiis: 1. primeer extensionn with all tthe other neecessary coomponents
except T
TTP, 2. prim
mer extensioon with all tthe necessarry components except tthe enzyme,, 3. primer
extensioon in presennce of tempplate-1 and primer
p
onlyy, 4. primer extension iin presence of primer
only without the otther componnents, 5. prrimer extenssion with dN
NTPs, 6. prrimer extenssion using
TCO-TT
TP instead of dTTP; B). Post-syynthesis booronic acid incorporation using T
TCO-TTP
primer extension
e
product and Tz-BBA, 20%
2
PAGE analysis: 1.. primer exttension prodduct using
dNTPs, 2.primer eextension pproduct usinng TCO-TT
TP instead of dTTP, 3. primer extension
product using TCO
O-TTP after reaction with Tz-BBA
A, 4. primerr extension pproduct usinng dNTPs
after reaacting with Tz-BBA; C
C). Structuree of Tz-BBA
A.
T primer extension pproducts werre studied uusing MALD
The
DI mass speectrometry. The
T TCOTTP priimer extensiion productt (Lane 2, F
Figures 1.8B
B and Appenndix) showeed a molecuular ion of
m/z 6710.2 (calculaated: 6710.44, [M+ H+])). Tz-BBA cclick labelinng product (Lane
(
3, Figgures 1.8B
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and Appendix) showed a molecular ion of m/z 7237.6 (calculated: 7238.6, [M+ Na+]). The
primer extension product using dNTPs was also reacted with Tz-BBA (Lane 4, Figure 1.8B).
The product gave a molecular ion of m/z of 6520.0 (calculated: 6519.3, [M+ H+]), which is the
same as the original extension product, suggesting no reaction with Tz-BBA, as one would have
expected. The mass spectrometric results further support the successful incorporation of one
TCO-TTP moiety into DNA molecule and boronic acid labeling of DNA.
To further explore the feasibility of incorporating multiple TCO-TTP into DNA, we
designed two more 21-mer templates complementary to the same 14-mer primer, template-2 (5’TCA GTC ACC AGC AAC CCG CTA-3’) and template-3 (5’-CAC GAC ACC AGC AAC
CCG CTA-3’). These templates contained 2 or 3 A in the sequence, respectively, that can
incorporate 2 or 3 TCO-TTP moieties into DNA. Based on previous optimization work using the
Klenow fragment,144 incorporation of additional modified TTP required higher temperature and
longer incubation time than incorporating a single modified TTP. Under harsh conditions,
Klenow fragment catalysis would give incomplete extension products and several blunt bands on
gel. As a result, we chose the KOD-XL DNA polymerase, a family B polymerase from
thermococcus kodakaraensis, which is more tolerant of unnatural TTP.153 Analysis using 20%
PAGE indicated successful primer extensions with the incorporation of both 2 and 3 Ts (Figure
1.9). Template-1 primer extension using dNTPs (Lane 1, Figure 1.9A) was conducted as positive
control. Primer extension products using TCO-TTP in place of dTTP were obtained with
template-1 (Lane 2, Figure 1.9A), template-2 (Lane 3, Figure 1.9A) and template-3 (Lane 4,
Figure 1.9A). As seen in Figure 2A, the electrophoretic mobility of primer extension products
decreased progressively with increasing number of TCO-TTP moieties, indicating successful
incorporation of multiple TCO-TTP units into DNA. To further confirm TCO-TTP’s
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incorporration and ssuccessful bboronic acidd labeling work,
w
the exttension prodduct using ttemplate-3
was furtther studiedd through reaaction with Tz-BBA inn a similar fashion
fa
as thhe results deescribed in
Figure 1. As show
wn in Figuree 2B, Tz-B
BBA-labeledd primer exxtension prooducts led tto a slowmoving band (Lanee 5). Such rresults are consistent with previouss findings inn similar stuudies.144 It
k
that H2O2 can ooxidatively cleave the bboronic acidd moiety leaaving a pheenol group
is well known
behind.1154 Thus wee also treateed the boroonic acid laabeled primer extensionn product w
with H2O2
(Lane 66, Figure 1..9B). The ffaster movinng band aftter H2O2 treeatment waas presumabbly due to
decreaseed moleculaar weight ass well as thee lack of thee boronic accid group, w
which tends tto interact
with Lew
wis bases inn the matrixx and thus prrovide a draag on mobiliity.

Figurre 1.9 Primeer extension incorporatin
ng multiple TCO-TTP aand post-syn
nthesis boron
nic acid
labeling.

A). Prim
mer extensioon incorporaating multipple TCO-TT
TP catalyzedd by KOD-X
XL DNA poolymerase,
20% PA
AGE analyssis: 1. prim
mer extensioon using tem
mplate-1 w
with dNTPs, 2. primer extension
using teemplate-1 w
with TCO-T
TTP in placce of TTP, 3. primer eextension using
u
templaate-2 with
TCO-TT
TP in place of TTP, 4. primer
p
extennsion using template-3 with TCO-TTP in placce of TTP;
B). Postt-synthesis bboronic acidd labeling of primer exttension prodduct using template-3 w
with TCOTTP inccorporation,, 20% PAGE
E analysis: 1. primer eextension wiith all the necessary
n
coomponents
except T
TTP, 2. prim
mer extensiion with dN
NTPs, 3. priimer extenssion using T
TCO-TTP inn place of
TTP; 4. primer exxtension prooduct usingg dNTPs reeacted with Tz-BBA, 5. primer extension
product using TCO
O-TTP reaccted with Tz-BBA, 6. Tz-BBA laabeled prim
mer extensioon product
(from laane 5) treateed with H2O2.
A
After
succeessful incorrporation off TCO-TTP
P into shortt DNA seqquences usinng primer
extensioons, we connducted PC
CR amplifications of a 90-mer DN
NA templatte (See expperimental
section for details).. Before thee incorporattion work, w
we investigaated amplifiication efficciencies of
three ccommerciallly availablee polymeraases, KOD
D-XL, Taq and Deepp VentR exxo-. PCR
amplificcations weree examinedd under the same condiitions for thhree polymeerases. The screening
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results showed thee highest effficiency byy KOD-XL (Lane 2, F
Figure 1.100A). Such rresults are
consisteent with prevvious work on using otther 5-modiffied deoxyuuridine-5’-triiphosphatess.139, 144 As
a result,, further PCR
R amplificaations were cconducted with
w the KO
OD-XL polyymerase. Acccording to
the TCO
O-TTP therm
mo-stabilityy test, optim
mized PCR aamplificatioon method was
w built baased on an
improveement of thhe CBT-TT
TP incorpooration workk.144 With TCO-TTP modified DNA, 30
thermal cycles weree run with 220 s meltingg at 90 oC, 20 s annealinng at 48 oC, and 30 s exxtension at
CR conditioon, TCO-TT
TP can be
72 oC, which gavee 10-min exxposure at 90 oC. Undder this PC
introducced into DN
NA sequencees in place of TTP. Following sim
milar conditiions as in thhe boronic
acid labbeling of prrimer extenssion produccts, PCR-am
mplified prooduct was also
a
reactedd with TzBBA for
fo boronic acid labelling. As shhown in Figure 1.10B
B, TCO-TT
TP was suuccessfully
incorporrated into 990-nt PCR product (L
Lane 3). Exxperiments uusing dATP
P, dCTP, annd dGTP,
without dTTP for P
PCR ampliffication werre used as a negative coontrol (Lanee 1) and dN
NTPs PCR
amplificcation as a ppositive conntrol (Lane 22). PCR-am
mplified TCO
O-TTP prodduct was reaacted with
Tz-BBA
A (Lane 4), lleading to a slow mobility band. B
Boronic acidd labeling coontrol experiiment was
perform
med with thee dNTPs PC
CR amplificcation produuct by reactting with Tzz-BBA (Lanne 5). As
expectedd, dNTP-PC
CR product didn’t reacct with Tz-B
BBA and gaave the sam
me mobility as dNTPPCR am
mplification product (Laane 2). The results dem
monstrate succcessful TC
CO-TTP incoorporation
during P
PCR and succcessful borronic acid laabeling by rreacting withh Tz-BBA.

Figu
ure 1.10 Postt-PCR boron
nic acid labeeling of amplified DNA w
with TCO-T
TTP incorpooration.

A). Pollymerase sccreening foor TCO-TT
TP incorporration, 15%
% PAGE annalysis: 1. KOD-XL
catalyzeed PCR prooduct using dNTPs, 2. KOD-XL ccatalyzed PCR
P
producct using TC
CO-TTP in
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place of TTP, 3. Taq catalyzed PCR product using dNTPs, 4. Taq catalyzed PCR product using
TCO-TTP in place of TTP; 5. Deep VentR catalyzed PCR product using dNTPs, 6. Deep VentR
catalyzed PCR product using TCO-TTP in place of TTP. B). Post-PCR boronic acid labeling of
amplified DNA product with TCO-TTP incorporation, 15% PAGE analysis: 1. PCR
amplification in absence of TTP, 2. PCR amplification with dNTPs, 3. PCR amplification using
TCO-TTP in place of TTP; 4. PCR amplification product using TCO-TTP reacted with Tz-BBA,
5. PCR amplification product using dNTPs reacted with Tz-BBA.
Encouraged by the results from TCO-TTP incorporation into a 90-nt DNA sequence and
successful post-PCR boronic acid labeling, we further explored incorporating TCO-TTP into a
published aptamer to see whether we can use the TCO-TTP handle for labeling DNA sequences
with other structural moieties, such as fluorophore. N37 is a known aptamer selectively targeting
the thrombospondin-1 (TSP-1) protein on the surface of inflamed endothelial cells with high
potential of atherosclerosis.155-156 Using the same PCR amplification conditions described above,
N37 was used as new template for amplifications. Tetrazine-FITC (fluorescein isothiocyanate
reacting with an amino handle of tetrazine, Tz-FITC, Figure 1.11B) was synthesized for postPCR fluorescent labeling of TCO-TTP modified DNA. We studied the incorporation of
fluorescein into a known aptamer155 N37 and the applicability of using such a fluorophorelabeled DNA for binding applications. TCO-TTP modified N37 (TCO37) (Lane 3, Figure 1.11A)
was obtained and analyzed with 15% PAGE after KOD-XL catalyzed PCR. This amplification
product generated fluorescein-labeled N37 aptamer (Lane 4, Figure 1.11A) after reacting with
Tz-FITC. Natural N37 aptamer (Lane 2, Figure 1.11A) was used as positive control. The product
of N37 (generated using dNTPs) reacting with Tz-FITC (Lane 5, Figure 1.11A) was used as
negative control for the fluorescein labeling experiments. As shown in Figure 4A, only the PCR
product with the trans-cyclooctene moiety reacted with Tz-FITC as indicated by the fluorescent
band (FITC channel, λem: 520 nm, Lane 4, Figure 1.11A). No fluorescence was detected in other
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lanes. Ethidium
E
broomide (EB)) staining reesults were consistent w
with successsful incorporation of
TCO-TT
TP and boroonic acid labbeling with 90-mer DN
NA template..

Figurre 1.11 Post--PCR FITC labelling of TCO-TTP iincorporatioon products using N37 teemplate

A). Posst-PCR FIT
TC labeling of TCO-TTP incorpooration prodducts using N37 tempplate, 15%
PAGE analysis:
a
1. PCR ampllification with
w all the essential coomponents except TTP
P, 2. PCR
amplificcation with dNTPs, 3. PCR ampllification ussing TCO-T
TTP in placce of dTTP
P; 4. PCR
n product
amplificcation produ
duct using T
TCO-TTP rreacted withh Tz-FITC,, 5. PCR amplificatio
a
using dN
NTPs reacteed with Tz-F
FITC; B). Structure of Tz-FITC.
T

1.2.4

C imagin
Cell
ng study of T
TCO-TTP modified
m
apptamer
B
Based
on thhe successfu
ful incorporaation of a ffluorophore into a know
wn N37 apttamer, we

wanted to explore its in vitroo cell fluorrescent imaging appliccations. In nnatural N377 aptamer
was determinned with 5’--FAM labelled primer, w
which has
studies, the bindingg affinity wiith TSP-1 w
a singlee fluorophoore attachedd in each aptamer seequence.155 However, with the ability to
incorporrate a fluoroophore using the tetraziine-trans-allkene chemiistry, it was possible to introduce
a fluoroophore in multiple
m
posiitions of thee TCO-moddified aptam
mer N37 (TCO37). Succh labeled
aptamerrs could hhave higherr fluoresceent intensityy without losing binnding affinnity. Thus
fluoresccent labelinng studies w
were conduucted using Hela cellss, which exxpress TSP--1 on the
surface.157 After inncubation w
with 1 µM of 5’-FAM
M N37 aptaamer (Figurre 1.12B) aand FITClabeled TCO37 apttamer (Figuure 1.12D) aat 37 oC for 30 min, thhe cells weere examineed under a
for details). Two contrrol experim
ments were
fluoresccent microsccope (see eexperimentaal section fo
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conducted with cell only (Figure 1.12A) and N37 (no click handle) reacted with Tz-FITC (Figure
5C). 4',6-Diamidino-2-phenylindole (DAPI) staining (for nuclei) was also used. Cells were
examined using three channels (Figure 1.12): (1) DAPI channel (λem: 461 nm; first row) for
nuclear staining; (2) FITC channel (λem: 520 nm, second row) for detecting the fluorescein
signal; (3) phase contrast channel for morphological observations (third row); and (4) Merged
channel, with images of DAPI, FITC and phase merged into one (fourth row). As one can see, all
cells stained normally with DAPI and have normal morphology under phase contrast, indicating
normal cell growth. However, only the cells treated with FITC-labeled TCO37 aptamer showed
significant fluorescent labeling in the fluorescein channel. Interestingly, the FAM-N37 labeled
cells did not show the same significant fluorescent labeling. The results so far indicate that
replacing T with TCO-T in aptamer N37 didn’t affect its binding affinity to TSP-1 and allowed
for fluorescent labeling of cells after the incorporation of a fluorophore. The ability to
incorporate multiple fluorophores could provide enhanced sensitivity for labeling. Conceivably,
the same approach can be used in other known aptamers for binding studies.
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Figure 1.12 Images of Hela cells were taken using a confocal microscope.

Fluorescent images of four samples were shown: A column: blank, cell only; B column: FAMN37 aptamer; C column: product of N37 aptamer reacting with Tz-FITC (negative control); D
column: FITC-labeled TCO37 sequence. Images were taken with 3 channels: 1. DAPI channel
(λem: 461 nm, first row); 2. FITC channel (λem: 520 nm, second row); 3. Phase contrast channel
(third row); 4. Images from the DAPI channel merged that of the FITC channel and phase
channel (fourth row)
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1.2.5

C
Cell-SELEX
X using borronic acid m
modified DN
NA

1.2.5.1 Selection pprocedure611
B
Boronic
aciid-modified DNA moleecules can bbe obtainedd by first inccorporating a general
handle ((TCO-TTP)) on a naturral nucleotide base andd then condduct PCR syynthesis usiing KODXL-DN
NA polymeraase. Subseqquently, thee TCO grouup was reaccted with a tetrazine teethered to
boronic acids throuugh a fast coopper-free cclick reactionn (Scheme 1.4).158 An initial librarry is 80-nt
DNA poool containiing 40 randoomized sites in the cennter, flankedd by 20-merr primers at each end.
For aptaamer selecttion work, single-stran
s
nded DNA ((ssDNA) iss critical forr binding bbecause of
their unnique threee-dimensional conform
mations.159-1660 There arre several m
methods reeported to
generatee ssDNA, including biotin–strep
b
ptavidin sepparations m
methods,161 lambda exxonuclease
digestioon162 and asyymmetric P
PCR.163 How
wever, accoording to preevious repoorts, asymm
metric PCR
has bettter performaance compaared to the cconventionall streptavidiin pull-dow
wn method.1664-166 Thus
in our sstudy, we uttilized 20:1 concentratiion ratio off FAM-labelled primer 1 (sense) too primer 2
(antisennse) in PCR
R and obtainned single-stranded seequences as the majoriity component. DNA
pools were
w
generatted using TC
CO-TTP annd other natu
tural nucleoside triphossphates withh catalysis
of KOD
D-XL DNA polymerase (see expeerimental seection for ddetails). PCR
R-amplifiedd products
were reaacted with bboronic acidd conjugatedd to tetrazinne (Tz-BBA
A, 1 mM) at room tempeerature for
1 h. T
The post-P
PCR modiffication prooducts of each rounnd were exxamined w
with 15%
polyacryylamide gell electrophorresis (PAGE
E).

Scheme 1.44 A schemattic representtation of DN
NA modificattions with a boronic acid
d
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HPAF II and MIA Paca cell lines were chosen to be the target and control cells
respectively in the selection. HPAF II and MIA Paca are both human pancreatic cancer cell lines,
which share many common features. However, one distinct difference between these two cell
lines is that HPAF II highly expresses MUC13 but MIA Paca is a MUC13-null cell line.167 This
makes them suitable for being a target cell line and a control cell line in the cell-SELEX
selection. The single-stranded sequences pool selected from each round was amplified with
FAM-labeled primer, which gave fluorescent sense ssDNA molecules. When the FAM-labeled
sequences bound to glycoprotein on cell surface, it would show obvious fluorescence enrichment
on cell surface under fluorescence microscope. Thus, binding of the selected sequence pool to
the target cell and control cells was monitored by fluorescent imaging after each round.
Starting from an initial 80-mer DNA pool, we synthesized ssDNA (4 µM), incorporated
boronic acid groups and incubated with target cell HPAF II for 30 min at 37 ⁰C. After
incubation, we discarded unbound sequences in buffer and collected cells that bound the target
cells. Then we heated the cell suspension to release the bound ssDNA through protein
denaturation. The sequences collected were used as the template in the next round PCR
amplification. In order to maximize the number of sequences that survives at the beginning of
selection, the first three rounds were performed without counter selection (no control cells
involved). According to the fluorescent images, fluorescence on cell surface progressively
increased with each round of selection, indicating that binding obviously increased after 3 rounds
of selection (Figure 1.13), which seems to be more efficient compared with previous reports.168170
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Figure 1.13 Fluorescent image of the first 3 selected pool binding to the target cell.

The second raw is the phase contrast images of the first raw. (The boronic-acid modified
sequences have a FAM fluorophore at the 5’ end. The selected pool after 3 rounds showed
binding, which is indicated with a white arrow in the figure.)
From the 4th round, the control cells were used in counter selections to remove the
sequences that also bind to the control cells, as well as to increase the specificity of selection.
Selected single-stranded sequences from the 3rd round were amplified with PCR and modified
with boronic acids. These modified ssDNA was firstly incubated with control cells to remove
sequences bound to MIA Paca, and followed by incubation with target cell line. As shown in
Figure 1.14, after the counter selection was introduced, binding intensity decreased substantially,
indicating a reduction in the number of sequences that bind to the target cells. Again, after three
additional rounds of selection, the binding appeared at 7th round and could be observed obviously
on cell surface (Figure 1.14). Analysis using 15% PAGE indicated successful incorporation of
boronic acid in the selected sequences after the 7th round (Figure 1.15b). As seen in Figure 1.15b,
the boronic acid-modified sequences (Lane 2) showed decreased electrophoretic mobility
compared to non-click DNA molecules (Lane 1), presumably because of the presence of the
boronic acid group and increased molecular weight and affinity to the gel matrix materials.
These results further suggest the high efficiency of selection using boronic-acid modified
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t
aptamerr in cell-SE
ELEX. The sequences collected ffrom the 7th
round off selection were
w
then

sequencced. Purity of sample for sequenncing was aanalyzed with 15% PA
AGE (Figuure 1.15c).
Comparred to negattive control sample (noo template added,
a
Lanee 1), selecteed pool ampplification
product (Lane 2) hhad a clearr fluorescennt band on gel, indicaating pure pproduct preepared for
sequenccing.

Figuree 1.14 Fluoreescent imagee of the 4th and 7th seleected pools b
binding to th
he target celll and the
control cell.

T
The second raw is the pphase contraast images of
o the first raaw.

Figuree 1.15 Schem
matic repressentations an
nd gel imagees for the 7th
h round.
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a. A schematic representation of boronic acid incorporated in DNA; b. 15% PAGE analysis of
boronic acid-modified sequences collected from 7th round; c. 15% PAGE analysis of PCR
product prepared for sequencing.

1.2.5.2 Sequencing and binding results
The selected DNA library was cloned into E. coli and sequenced (see experimental
section for details). Next-generation (Nextgen) sequencing was also used to analyze the enriched
library (Tables 1.1 and 1.2). The sequencing results were analyzed with sequence alignment. To
avoid misinterpretation, any sequence with fewer than 70 nucleotides in the library was
discarded. Interestingly, sequences randomly selected from colonies and those obtained from
Nextgen sequencing showed several identical sequences (highlighted in red). The identical high
abundance sequences were the major components in selected pool and were considered potential
aptamer candidates. Furthermore, these results indicated that the selection and enrichment
progress approached to the end point of selection. As the result, the three identical as well as the
most abundant sequences (3UB2, 3B6, 7UB4) were examined as for binding studies. The
binding affinity towards HPAF II and MIA Paca cell lines were analyzed by flow cytometry and
calculated by measuring fluorescence per cell as increasing concentration of selected
sequences.161
Table 1.1 Sequencing results from cloning
Name

Sequence

3B4

CCT TCG TTG TCT GCC TTC GTG ACC ATG TGA CTG CAG CAC CCA GAC GGC CGC CAC CCT TCA
GAA TTC GCA CCA

3B6

CCT TCG TTG TCT GCC TTC GTG GGC CGA GGC TGG GCG GCG GGC GCG GCC ATG TGG GGG GGG
ACC CTT CAG AAT TCG CAC CA

3UB2

CCT TCG TTG TCT GCC TTC GTG GGC CGG GTG GAC CGA GCA TAA GGC GGG GGA GGT GGC GGC
ACC CTT CAG AAT TCG CAC CA

28
7UB4

CCT TCG TTG TCT GCC TTC GTA CCC CAC ACG AAC CCC GAC GCG CCC GGG CAT CCT GGC TGC
ACC CTT CAG AAT TCG CAC CA

7UB5

CCT TCG TTG TCT GCC TTC GTG CGC CGT GCA GAC GGT ACC CGA CCC CCG CCT CCG GCC ACC
ACC CTT CAG AAT TCG CAC CA

Table 1.2 Sequencing results from Nextgen sequencing
Name

Sequence

Abundance

CCT TCG TTG TCT GCC TTC GTG GGC CGG GTG GAC CGA GCA TAA GGC GGG GGA
3UB2

GGT GGC GGC ACC CTT CAG AAT TCG CAC CA

4.63%

CCT TCG TTG TCT GCC TTC GTG GGC CGA GGC TGG GCG GCG GGC GCG GCC ATG
3B6

TGG GGG GGG ACC CTT CAG AAT TCG CAC CA

2.25%

CCT TCG TTG TCT GCC TTC GTA CCC CAC ACG AAC CCC GAC GCG CCC GGG CAT
7UB4

CCT GGC TGC ACC CTT CAG AAT TCG CAC CA

0.70%

CCT TCG TTG TCT GCC TTC GTG GGC CGG GGT GGA CCG AGC ATA AGG CGG GGG
Oligo4

AGG TGG CGG CAC CCT TCA GAA TTC GCA CCA

0.70%

CCT TCG TTG TCT GCC TTC GTG GGC CGG GTG GAC CGA ACA TAA GGC GGG GGA
Oligo5

GGT GGC GGC ACC CTT CAG AAT TCG CAC CA

0.28%

CCT TCG TTG TCT GCC TTC GTG GGC CGA GGC TGG GCG GCG GGC GCG GCC ATG
Oligo6

TGG GGT GGG ACC CTT CAG AAT TCG CAC CA

0.28%

CCT TCG TTG TCT GCC TTC GTG GGC CGA GGC TGG GCG GCG GGC GCG GCC ATG
Oligo7

TGG GGG GGG GAC CCT TCA GAA TTC GCA CCA

0.28%

To obtain sense ssDNA and control the concentration of single-stranded sequence for
bind studies, lambda exonuclease digestion was used to remove antisense sequences.162
Conceivably, enzyme digestion of phosphate-labeled sequences and followed by 10k cut-off
filtration would gave more accurate concentration of single-stranded sequences of aptamer
candidates compared to asymmetric PCR.166 Thus, the sequences were synthesized using
phosphate-modified complementary template, FAM-labeled sense primer 1 and TCO-TTP
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throughh primer eextension. L
Lambda exxonuclease cleaved aand digesteed phosphaate-labeled
antisensse sequence, resulting iin FAM-labbeled single strand of apptamer canddidates (Figgure 1.16).
As seenn in gel, w
with treatm
ment of lam
mbda exonuuclease, doouble-strandded sequencces bands
disappeaared and new low moobility bandds emerged. It has beeen reportedd that ssDN
NA moved
slower than dsDNA
A because of its secoondary struccture.171 So the gel reesults repressented the
successfful digestioon of antiseense sequennces and geeneration off aptamer ccandidates. Then, the
single-stranded seqquences weere incorporrated with boronic aciid through click reacttion under
room temperature. Stock solutiions of aptaamer candiddates were prrepared withh series diluution from
2 µM.

Figgure 1.16 15%
% PAGE an
nalysis of dsD
DNA and ssD
DNA obtain
ned from lam
mbda exonucclease
treatmentt of aptamerr candidatess

S
Stock
soluttions at diffferent conceentrations oof aptamer candidates were incubbated with
HPAF II
I for 30 m
min at 37 ⁰C
C. Washingg buffer waas used to wash
w
out nnon-bound sequences,
s
leaving FAM-labeeled aptameer candidates bound oon cell surrface. Thuss the cells that had
would have sstrong fluorrescence. Thhe fluoresceence changees per cell
sequencces bound too surface w
as increeasing conccentration oof selected sequences were monnitored by flow
f
cytom
meter. Ten
thousannd of cells w
were counted in each exxperiment. The fluoresscence intennsities of ceells, which
were inccubated witth different concentratioon of sequeences, were recorded (row 2-8, Figgure 1.17).
Bindingg studies w
were designed to exam
mine the biinding affinnity and sppecificity off aptamer
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candidates. Taking the most abundant sequence 3UB2 as an example, four sets of experiments
were included. Binding studies of boronic acid-modified aptamer candidate (3UB2-BBA,
column 5, Figure 1.17) and non-click, TCO-modified aptamer candidate (3UB2, column 4,
Figure 1.17) were expected to show good affinity, especially boronic acid modified sequences.
Two control experiments were designed to confirm binding efficiency and specificity. Because
of low PCR efficiency in incorporating modified thymidine, the selected aptamer candidates only
had 3 thymidine nucleosides among 40-nt randomized sites. Thus one control sequence was ATrich sequence synthesized with natural nucleosides triphosphate (control sequence, column 2,
Figure 1.17). Another control sequence (nT-3UB2, column 3, Figure 1.17) was the same
sequence as aptamer candidate except using natural TTP instead of TCO-TTP. As shown in
Figure 5, TCO-modified aptamer candidate 3UB2 (column 4) and boronic acid-modified aptamer
candidate 3UB2-BBA (column 5) had obvious increased binding fluorescence peak starting at
125 nM. The newly appearing fluorescence binding peak indicated up to 15% of cells were
bound with FAM-labeled sequences. The binding peak fluorescence percentage increased to
more than 90% at 500 nM of sequences binding, which demonstrated strong binding between
aptamer candidates and target cells. Under the same conditions, control sequence (column 2)
didn’t have obvious fluorescence increases compared to aptamer candidates. These binding
results confirmed that selected sequences would have binding affinity to target cells. Another
control nT-3UB2 (column 3) also didn’t show high fluorescence intensity compared to aptamer
candidates, which demonstrated only TCO-TTP incorporated DNA molecules have strong
binding to HPAF II. Other aptamer candidates (3B6 and 7UB4) binding affinity were also tested
under the same condition (Figure 1.18). The binding results indicated good binding affinity of
aptamer candidates to target cells. Compared to the data above, 3UB2 had the highest binding
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affinity to HPAF II, while 33B6 and 77UB4 had little lowerr affinity. T
This concluusion was
mer candidate in selectedd pool.
correlateed to the abbundance off each aptam

Figurre 1.17 Bind
ding studies oof 3UB2 apttamer candid
date to HPA
AF II cell usiing flow cytoometry.

Flow cyytometer ressults of fouur sets of exxperiments were shown: 1. AT-rrich control sequence
(columnn 2); 2. 3UB
B2 aptamer candidate using
u
naturaal TTP insteead of TCO
O-TTP (coluumn 3); 3.
TCO-TT
TP incorporrated 3UB2 aptamer canndidate (collumn 4); 4. B
Boronic aciid-incorporaated 3UB2
aptamerr candidate (column
(
5). Data repressents the avverage of thrree independdent experim
ments.
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Figu
ure 1.18 Bind
ding studies of 3B6 and 7UB4 aptam
mer candidaates to HPAF
F II cell usin
ng flow
cytometryy.

Flow cyytometer ressults of fourr sets of expperiments w
were shown: 1. TCO-T
TTP incorpoorated 3B6
aptamerr candidate (column 2);; 2. Boronicc acid-incorrporated 3B66 aptamer candidate
c
(ccolumn 3);
3. TCO
O-TTP incorrporated 7U
UB4 aptameer candidatee (column 44); 4. Boronnic acid-inccorporated
7UB4 aaptamer caandidate (column 5). Data repreesents the average of
o three inddependent
experim
ments.
D
During
the selection prrocess, we applied
a
neggative selecttion against control MU
UC13-null
cell linee (MIA Paca) to increease the seelection stringency. Thhe binding affinities of aptamer
candidaates to controol cells werre also evaluuated by flow
w cytometeer. As mentiioned abovee, four sets
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of binding studies were conducted: 1. AT-rich control sequence (control sequence, column 2,
Figure 1.19); 2. 3UB2 aptamer candidate using natural TTP instead of TCO-TTP (nT-3UB2,
column 3, Figure 1.19); 3. TCO-TTP incorporated and non-click 3UB2 aptamer candidate
(3UB2, column 4, Figure 1.19); 4. Boronic acid-incorporated 3UB2 aptamer candidate (3UB2BBA, column 5, Figure 1.19). As seen in Figure 1.19, the aptamer candidate didn’t show obvious
binding peak and fluorescence increase with incubation of control cell up to 2 µM. The control
cell binding studies indicated that the aptamer candidates had good specificity between two
pancreatic cancer cell lines as expected, resulting in the capability to recognize and differentiate
these two cancer cell lines.
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Figurre 1.19 Bindiing studies oof 3UB2 aptaamer candid
date to MIA Paca cell ussing flow cyttometry.

Flow cyytometer ressults of fouur sets of exxperiments were shown: 1. AT-rrich control sequence
(columnn 2); 2. 3UB
B2 aptamer candidate uusing naturaal TTP insteead of TCO
O-TTP (coluumn 3); 3.
TCO-TT
TP incorporrated 3UB2 aptamer canndidate (collumn 4); 4. B
Boronic aciid-incorporaated 3UB2
aptamerr candidate (column
(
5). Data repressents the avverage of thrree independdent experim
ments.
I needs to bbe noted thaat boronic acid-modifieed sequences didn’t shoow obvious difference
It
compareed to those without in bbinding studdies. We woould think thhese results might becaause of the
binding buffer we used in seelection proocess. As itt known, booronic acidss have goood binding
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affinity to carbohydrates. Although glucose is not as a good binder as fructose, in the presence of
25 mM of glucose in the buffer, most of boronic acids would be saturated by glucose binding. As
a result, it might be hard to select sequences that can bind differently to target cells with boronic
acid-modified and TCO-TTP modified. The data above demonstrated that selected modified
sequences are potential aptamers for pancreatic cancer cell recognition, the target MUC13.
Further structural studies and target identification work need to be conducted.
1.3
1.3.1

Experimental Section
General Information
Solvents and reagents were purchased from VWR International, Oakwood Product Inc.,

or Sigma-Aldrich Co. and used without purification unless specified otherwise. When necessary,
solid reagents were dried under high vacuum. Reactions with compounds sensitive to air or
moisture were performed under argon. Solvent mixtures are indicated as volume/volume ratios.
Thin layer chromatography (TLC) was run on Sorbtech W/UV254 plates (0.25 mm thick), and
visualized under UV-light. Flash chromatography was performed using Fluka silica gel 60 (mesh
size: 0.040-0.063 mm) using a weight ratio of ca. 30:1 for silica gel over crude compound. 1H,
13

C, and

31

P-NMR spectra were recorded on a Bruker Avance 400 spectrometer (400, 100, and

166 MHz, respectively) in deuterated chloroform (CDCl3), methanol-d4 (CD3OD), and DMSO-d6
with either tetramethylsilane (TMS) (0.00 ppm) or the NMR solvent as the internal reference.
HPLC purification for trans-cyclooctene triphosphate (TCO-TTP) was carried out using a
Shimadzu LC-20AT VP system with a Zobax C18 reversed-phase column (9.4 mm × 25 cm).
The sample was eluted (3 mL/min) with buffer A (20 mM triethylammonium acetate, pH 6.97.1) and buffer B (50% acetonitrile, 20 mM triethyl ammonium acetate) with the following: 0
min 0% B; 20 min 20% B; 30 min 100% B; 38 min 100% B; 40 min 0% B; and 45 min 0% B.
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DNA primers and templates were purchased from Integrated DNA Technologies. Klenow
fragment (3’-5’ exo), Taq. DNA polymerase and Deep VentR (exo-) DNA polymerase were
purchased from New England Biolabs. KOD-XL DNA polymerase was purchased from EMD
Chemicals. Reaction buffers were used as provided. Reaction buffers were used as provided.
SELEX binding buffer contained: 4.5 g/L glucose, 5 mM MgCl2, 100 mg/L yeast tRNA, 1g/L
bovine serum albumin in phosphate-buffered saline.161 SELEX washing buffer components are:
4.5 g/L glucose and 5 mM MgCl2 in phosphate-buffered saline.161
HPAF II and MIA Paca cell lines were obtained from Dr. Subhash Chauhan’s lab
(University of Tennessee, Health Science Center). Cells were grown in DMEM culture medium
supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. Fluorescent imaging
was conducted using Zeiss fluorescent microscope. The Qiagen PCR cloning kit was obtained
from Qiagen. The flow cytometer used is BD LSRFortessa.
1.3.2

Experimental Procedure for the Synthesis of TCO-TTP
Synthesis of (E)-Cyclooct-4-en-1-yl (2,5-dioxopyrrolidin-1-yl) carbonate 22: Compound

22 was prepared starting from cyclooctadiene (17) in four steps following literature
procedures.172
Synthesis of 5-(3-Aminoprop-1-yn-1-yl)-1-((2R,4S,5R)-4-hydroxy-5 (hydroxyl-methyl)
tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione 26: Compound 26 was synthesized starting
from 5-odo-2’-deoxyuridine (23) in two steps following literature procedures.139, 173
Synthesis of TCO-T, (E)-Cyclooct-4-en-1-yl(3-(1-((2R,4S,5R)-4-hydroxy-5-(hydroxylmethyl)tetrahydrofuran-2-yl) 2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)prop-2-yn-1-yl) carbamate 27: To a mixture of succimidyl ester 22 (134 mg, 0.5 mmol) and amine modified
deoxyuridine 26 (168 mg, 0.6 mmol) in DMF 10 mL was added DIPEA (129 mg, 1 mmol). The
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reaction mixture was wrapped in foil and stirred in r.t. for 12 h. Reaction solution was
concentrated under reduced pressure and purified with silica gel chromatography (12% MeOH in
DCM) to give a white solid (108 mg, yield 52%). 1H NMR (methanol-d4): 8.25 (s, 1H), 6.25 (t,
J = 6.4 Hz, 1H), 5.58-6.20 (m, 1H), 5.47-5.57 (m, 1H), 4.05 (s, 2H), 3.95-3.81 (m, 1H), 3.733.77 (m, 2H), 3.24-3.37 (m, 2H), 2.26-2.37 (m, 4H), 2.21-2.25 (m, 1H), 1.99-2.00 (m, 4H), 1.931.98 (m, 2H).

13

C NMR (methanol-d4): 163.1, 149.8, 144.0, 134.7, 132.4, 128.4, 98.6, HRMS

(ESI) for C21H27N3O7 [M+H]+ Cacld: 434.1849; Found: 434.1899.
Synthesis of TCO-TTP, (E)-Cyclooct-4-en-1-yl(3-(1-((2R,4S,5R)-4-hydroxy-5-(((hydroxyl((hydroxy(phosphonooxy)phosphoryl)oxy)phosphoryl)oxy)methyl)tetrahydrofuran-2-yl)-2,4dioxo-1,2,3,4-tetrahydropyrimi-din-5-yl)prop-2-yn-1-yl)carbamate 28: To a solution of TCO-T
26 (69 mg, 0.16 mmol) and proton sponge (42 mg, 0.19 mmol, pre-dried in vacuum over P2O5
overnight) in anhydrous trimethylphosphate (0.6 mL) was added freshly distilled POCl3 (18 µL,
0.19 mmol) dissolved in anhydrous trimethylphosphate (0.2 mL) dropwise via a syringe with
stirring under argon at 0 °C. The reaction mixture was further stirred in an ice-bath for 2 h and
then a solution of tributylammonium pyrophosphate (226 mg, 0.48 mmol) and tri-n-butylamine
(0.4 mL,) in 1.0 mL of anhydrous DMF was added in one portion. The mixture was stirred at RT
for 10 min and then triethylammonium bicarbonate solution (0.1 M, pH 8, 11 mL) was added.
After stirring at r.t. for an additional 1 h, the resulting reaction mixture was transferred to a 50mL centrifuge tube. Then EtOH (33 mL) was added followed by 3 M NaCl solution (1.0 mL).
After vortexing for 10 sec, the centrifuge tube was placed at -80 oC for 1 h, and then centrifuged
at 5000 rpm for 20 min. After removing the supernatant, the resulting pellet was purified by
HPLC and lyophilized to give a pale white powder (32 mg, 32%). 1H NMR (D2O): 8.06 (s, 1H),
6.18 (t, J = 6.8 Hz, 1H), 5.58-6.20 (m, 1H), 5.47-5.57 (m, 1H), 4.16-4.25 (m, 2H), 4.08-4.12 (m,
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3H), 4.0 (d, J = 7.2 Hz, 1H), 2.25-2.34 (m, 5H), 1.88-1.98 (m, 3H), 1.35-1.86 (m, 4H). 13C NMR
(D2O):179.7, 164.6, 158.0, 150.0, 144.8, 135.6, 133.4, 99.2, 82.4, 73.2, 70.5, 65.3, 46.6, 40.4,
38.7, 37.8, 33.7, 32.0, 30.6, 22.2, 8.2;
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P NMR (D2O) -10.9, -11.6, -23.3. MS (ESI) for

C21H30N3O16P3 [M-H]- Cacld. 672.08; Found: 672.1
1.3.3

Experimental Procedure for the Synthesis of Tz-BBA
Synthesis of 4,4'-(1,2,4,5-tetrazine-3,6-diyl)diphenol: Compound was prepared starting

from 4-hydroxybenzonitrile in two steps following literature procedures.174
Syntheis of Tz-BBA (29): To a solution of diphenol compound (133 mg, 0.5 mmol) was
added 4-(bromomethyl) phenylboronic acid (219 mg, 1.3 mmol), CsCO3 (488 mg, 1.5 mmol),
and NaI (30 mg, 0.2 mmol) in acetone (20 mL). The mixture was heated to reflux and stirred at
56 oC overnight. The solution was concentrated under vacuum and acidified with 1M HCl. The
residue was washed with EtOAc and MeOH to afford Tz-BBA 29. 1H NMR (DMSO-d6): 8.47
(d, J = 8 Hz, 4H), 7.83 (d, J = 8 Hz, 4H), 7.46 (d, J = 8 Hz, 4H), 7.31 (d, J = 8 Hz, 4H), and 5.28
(s, 4H). HRMS (ESI) for C28H24B2N4O6 [M+H]+ Cacld: 534.1882; Found: 535.1965.
1.3.4

Experimental Procedure for the Synthesis of Tz-FITC
Synthesis

of

2,5-Dioxopyrrolidin-1-yl

4-(6-(pyrimidin-2-yl)-1,2,4,5-tetrazin-3-yl)

benzoate: Compound was prepared starting from pyrimidine-5-carbonitrile in three steps
following literature procedures.175
Synthesis

of

5-(3-(2-Aminoethyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)

benzoic acid: Compound was prepared starting from commercially available fluorescein
isothiocyanate (FITC) in one step following literature procedures.176
Synthesis of Tz-FITC (30): To a mixture of tetrazine benzoate compound (188 mg, 0.5
mmol) and FITC compound (112 mg, 0.25 mmol) in MeOH (20 mL) was added Et3N (55 mg,
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0.5 mmol). The mixture was stirred at r.t. overnight. The reaction mixture was acidified to pH 2
and extracted with DCM. Residue was concentrated in vacuo and purified with silica gel
chromatography (20% MeOH in DCM) to give solid product with 40% yield. 1H NMR (DMSOd6): 10.42 (s, 1 H), 9.21 (d, J = 4.8, 2 H), 8.97 (s, 1 H), 8.67 (d, J = 8.2, 2 H), 8.48 (br, 1 H), 8.30
(s, 1 H), 8.21 (d, J = 8.2, 2 H), 7.85 (t, J = 4.8, 1 H), 7.80 (d, J = 7.9, 1 H), 7.18 (d, J = 8.4, 1 H),
6.69 (s, 2 H), 6.59 (m, 4 H), 3.78 (s, 2 H). HRMS (ESI) for C36H25N9O6S [M-H]- Cacld:
710.1549; Found: 710.1589.
1.3.5

Studies of the reaction kinetics between TCO-TTP and Tetrazine

1.3.5.1 Study of reaction kinetics between TCO-TTP and 4-(6-(pyrimidin-2-yl)-1,2,4,5tetrazin-3-yl) benzoic acid
To a solution of TCO-TTP in H2O was added a solution of 4-(6-(pyrimidin-2-yl)-1,2,4,5tetrazin-3-yl)benzoic acid (31, Tz-pym, core structure of Tz-FITC) aqueous solution to afford a
final concentration of 20, 25, 30, and 40 μM for TCO-TTP, and a final concentration of 2 μM for
Tz-pym. The resulting mixture was examined by monitoring its absorption at 327 nm. Using
established procedures,147 the second-order rate constant was determined to be 1087 M-1.s-1.

Scheme 1.5 Reaction between TCO-TTP and Tz-pym
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Figu
ure 1.20 Dettermination of the secon
nd order ratee constant foor the reactiion in Schem
me 1.5.

Left: Deeterminationn of the seccond order rate
r constannt for the reaaction in Sccheme 1.5: T
TCO-TTP
final cooncentrationn: 20, 25, 300, 40 μM; Tz-pym finnal concentrration: 2 μM
M. Second order rate
constantt K2= 1087 M-1.s-1. Rigght: Determiination of thhe pseudo ffirst order raate constant at 25 µM
TCO-TT
TP. Data reppresents thee average off three indeppendent expeeriments.
1.3.5.2 Study of rreaction kinetics betweeen TCO-TT
TP and 3,6-ddiphenyl-1,22,4,5-tetrazzine
T a solution of TCO
To
O-TTP in H2O was addded an aquueous soluttion of 3,6--diphenyl1,2,4,5-ttetrazine (33, Tz-ph, coore structuree of Tz-BBA) to affordd a final conncentration of 30, 40,
50 and 60
6 μM for T
TCO-TTP, aand a final cconcentratioon of 3 μM for Tz-ph. T
The resultinng mixture
was exaamined by monitoringg its absorpption at 3911 nm. Usingg establisheed procedurres,147 the
second-order rate constant wass determinedd to be 27 M-1.s-1.
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Figu
ure 1.21 Dettermination of the secon
nd order ratee constant foor the reactiion in Schem
me 1.6.

Left: Deeterminationn of the seccond order rate
r constannt for the reaaction in Sccheme 1.6: T
TCO-TTP
final cooncentrationn: 30, 40, 550, 60 μM; Tz-ph finaal concentraation: 3 μM
M. Second order rate
constantt K2= 27 M-1.s-1. Rightt: Determinnation of thee pseudo firrst order ratte constant at 60 µM
TCO-TT
TP. Data reppresents thee average off three indeppendent expeeriments.
1.3.6

E
Experiment
tal Procedu
ure of enzym
matic incorpporation of TCO-TTP aand boronicc acid
l
labeling

1.3.6.1 Experimen
ntal Proceddure for Kleenow Fragm
ment Catalyzzed Primer Extension::
A 50 µL reeaction mixtture of conttained 21-nnt template (5’-GGT
(
TC
CC ACC A
AGC AAC
CCG CT
TA-3’ (20 µ
µM)), 14-ntt primer (5’-TAG CGG
G GTT GCT
T GG-3’ (200 µM)), Tris-HCl (10
mM), N
NaCl (50 mM
M), MgCl2 (10
( mM), diithiothreitol (1 mM) at pH 7.9, Kleenow fragment (0.5 U
µL-1), ddATP, dCTP
P, dGTP, annd dTTP (oor TCO-TTP
P) (200 µM
M). Reactionns were perfformed by
incubatiing the preppared soluttions at 25 oC for 30 min. The primer
p
exteension prodducts were
analyzedd by 20 % PAGE.
P
1.3.6.2 Experimen
ntal Proceddure for KO
OD-XL Cataalyzed Primeer Extensioon:
A 50-µL reeaction mixxture contaiined 21-nt template (T
Template-2: 5’-TCA GTC
G
ACC
AGC A
AAC CCG C
CTA-3’, Tem
mplate-3: 5’’-CAC GAC
C ACC AGC
C AAC CC
CG CTA-3’ (20 µM)),
14-nt prrimer (5’-TAG CGG G
GTT GCT G
GG-3’ (20 µM)), Tris--HCl (10 m
mM), NaCl (50 mM),
MgCl2 (10
( mM), ddithiothreitol (1 mM) att pH 7.9, K
KOD-XL (0..5 U µL-1), dATP, dCT
TP, dGTP,
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dTTP, or TCO-TTP (200 µM). Reactions were performed by incubating the prepared solutions at
90 oC for 1 min, 20 oC for 1 min, and 66 oC for 20 min. The primer extension products were
analyzed by 20 % PAGE.
1.3.6.3 Experimental Procedure for Post-synthesis Labeling of Primer Extension Products
with Tz-BBA:
The primer extension product TCO-DNA21 was purified using Millipore Amicon 3 kDa
spin column. 2 μL of 10 mM Tz-BBA in DMSO was added into pre-purified TCO-DNA21 (20
μL). The reaction was allowed to vortex at r.t. for 15 min. The negative control experiment was
performed following the same procedure except using dNTPs-DNA21, the primer extension
product using dNTPs and other reagents. The resulting DNA products after post-synthesis
modification were purified with Millipore Amicon 3 kDa spin column and analyzed by 20 %
PAGE.
1.3.6.4 Experimental Procedure for PCR Incorporation and Post-PCR Labeling of TCOTTP:
A 50-μL PCR mixture contained DNA 90-nt template (PBA, 5’-CCT TCG TTG TCT
GCC TTC GTG AGC GGA GTC AGA CGC ACG CTC GTA CCT GTG CGC AAG CAC TAT
GAC GGA CAC CCT TCA GAA TTC GCA CCA-3’, 10 nM), 20-nt primer 1 (5’-TGG TGC
GAA TTC TGA AGG GT-3’, 1 μM), 20-nt primer 2 (5’-CCT TCG TTG TCT GCC TTC GT-3’,
1 μM), dATP, dCTP, dGTP, dTTP or TCO-TTP at a concentration of 200 μM, 0.5 U μL-1 KODXL DNA polymerase and 1× reaction buffer as provided by vender. Thirty thermal cycles were
conducted with melting at 90 °C for 20 s, annealing at 48 °C for 20 s, and extending at 72 °C for
30 s with initial denaturing at 90 °C for 2 min and final extension at 72 °C for 5 min. The PCR
products were then analyzed by 15% PAGE.
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Post-synthesis labeling of the PCR products was performed using similar procedures as
those for primer extension. Specifically, TCO-DNA90 prepared from PCR was purified using
Millipore Amicon 10 kDa spin column. Pre-purified TCO-DNA90 (20 μL) was then added to the
2 μL of 10 mM Tz-BBA DMSO solution, which was further reacted at r.t. for 30 min. The
negative control experiment was performed following the same procedure except using dNTPsDNA90, the PCR product using dNTPs and other reagents. The resulting DNA product after postsynthesis modification was purified with Millipore Amicon 10 kDa spin column and analyzed by
15% PAGE.
1.3.6.5 Experimental Procedure of Fluorescence Labeling and Cell Imaging Studies:
The PCR mixture of a final volume of 50 μL contained DNA 86-nt template (N37, 5’ATA CCA GCT TAT TCA ATT CTG CCG GGA ACA CCG CGT GGC TCT CTG CAA CGC
CCA GGA CAT ACC ACA TTA GAT AGT AAG TGC AAT CT-3’ 10 nM each), 18-nt primer
1 or 5’-FAM 18-nt primer 1 (5’-(FAM)-ATA CCA GCT TAT TCA ATT-3’, 1 μM), primer 2
(5’-AGA TTG CAC TTA CTA TCT-3’, 1 μM),155 dATP, dCTP, dGTP, dTTP or TCO-TTP at a
concentration of 200 μM, 0.5 U μL-1 KOD-XL DNA polymerase and 1× reaction buffer as
provided by vender. PCR thermal cycles were conducted as previous incorporation. Post-PCR
labeling using Tz-FITC was performed with similar procedures as previous incorporation. The
FITC-labeled DNA product was purified with Millipore Amicon 10 kDa spin column and
analyzed by 15% PAGE.
HeLa cells were seeded on rectangular coverslips in a 6-well plate until it achieved 90%
coverage on surface before the imaging experiment and were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% PNS at 37
°C with 5% CO2. The cells were then incubated with either FAM-N37 aptamer, or FITC-labelled
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TCO37 aptamer at the same concentration in SELEX binding buffer161 for 30 min at 37 °C. After
washing with phosphate buffered saline (PBS) for 2 times, the cells were fixed with ice-cold
methanol for 5 min. Thereafter, the coverslips containing the cells were mounted onto the slides
and imaged with a fluorescent microscope.
1.3.7

Experimental procedure of cell-based SELEX using boronic acid-modified DNA
molecules

1.3.7.1 Initial DNA pool preparation
The initial ssDNA library comprised of 80 bp, with a random 40 bp sequence in the
middle flanked by 20 bp primers at 5’ and 3’ ends (5’-CCT TCG TTG TCT GCC TTC GTN
NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN ACC CTT CAG
AAT TCG CAC CA-3’). The initial DNA pool was dissolved in DI water to make 1 µM stock
solution. The initial pool was first amplified with FAM-labeled primer (5’-FAM-CCT TCG TTG
TCT GCC TTC GT-3’) and TCO-TTP to incorporate TCO-TTP into the sequences through PCR.
Asymmetric PCR condition and amplification cycle program were as following: DNA library
template (40 nM), FAM-labeled primer (4 µM), reverse primer (5’-TGG TGC GAA TTC TGA
AGG GT-3’, 200 nM), dATP (396 µM), dCTP (396 µM), dGTP (396 µM), TCO-TTP (1.188
mM), and KOD XL DNA polymerase (0.025 U/µL) in 500 µL. Thirty thermal cycles were
conducted with melting at 90 °C for 20 s, annealing at 48 °C for 20 s, and extending at 72 °C for
30 s with initial denaturing at 90 °C for 2 min and final extension at 72 °C for 5 min. TCOmodified sequences prepared from PCR was purified using Millipore Amicon 10 kDa spin
column. Pre-purified sequences solution (480 μL) was then added to the 24 μL of 10 mM TzBBA DMSO solution, which was further reacted at r.t. for 1 h. The boronic modified products
were then analyzed by 15% PAGE. This is the “0 round pool”.
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1.3.7.2 Preparation of target cell and control cell
The HPAF II cells (target cell) and MIA Paca cells (control cell) were cultured in
DMEM/F-12 media and DMEM media, respectively, supplemented with 10% fetal bovine serum
and 1% penicillin-streptomycin at 37 °C with 5% CO2. The cells were cultured in the 5.0 cm
diameter cell culture dish until it achieved 90% coverage on surface before incubation.
1.3.7.3 General selection procedure
The target cell was incubated with the “0 round pool” (450 μL) in 10 mL SELEX binding
buffer for 30 minutes at 37 °C. The cells were then washed 3 times with SELEX washing buffer
and collected using a cell scraper. The collected cells were re-suspended in 250 µL DIH2O and
heated for 10 minutes at 90 °C to release the sequences. The suspension was centrifuged at 1500
rpm for 4 minutes. The supernatant collected was the template for the “1st round pool”. Next
round sequence was synthesized using template selected from last round (100 µL), FAM-labeled
primer and TCO-TTP through similar procedure stated above.
1.3.7.4 Negative selection procedure
After 3 rounds, a counter selection was introduced by incubating the sequence pool with
the control cells (MIA Paca) for 30 minutes at 37 °C. Discard the bound sequences that are
attached to control cells. The sequences that remained unbound to the control cells were further
incubated with the target cells following the similar procedure as described above. Fluorescence
imaging was used to monitor the binding of each round pool selected against the target cells.
1.3.7.5 Monitoring the progress of selection
The cells were cultured on coverslips in a 6-well plate until it achieved 90% coverage on
surface before the imaging experiment. 100 µL of the selected pool was dissolved in 2 mL of
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culture medium and incubated with the cells for 30 minutes at 37 °C. The cells were then washed
2 times with PBS and fixed with 4% paraformaldehyde for 30 minutes at room temperature. The
coverslips with the cell sample were mounted onto glass slides by using hard set mounting
medium containing DAPI. The slides were imaged under FITC, or DAPI, or phase contrast
channel by fluorescent microscope.
1.3.7.6 Cloning and sequencing of enriched pools
After binding was observed by fluorescent imaging, the sequences in the selected pool
was cloned and sequenced for identification. The selected pool was prepared with the same
procedure in pool amplification, except using non-labeled primer instead of FAM-labeled
primer. 2 µL of the PCR product was added into the ligation-reaction mixture and incubated at 4
°C for 30 minutes. The competent cells were thawed on ice and incubated for 5 minutes on ice
after adding 2 µL of the ligation mixture. The competent cell tubes were then heat-shocked in 42
°C water bath for 1 minute, followed by incubation on ice for 2 minutes. 500 µL of the SOC
medium was added into the competent cell tube and 50 µL was spread onto one LB plate. The
colonies were allowed to grow for 16 hours at 37 °C in an inverted plate position. The white
colonies on the LB plate was picked and suspended into 5 mL of liquid LB medium and shaken
vigorously for 12 hours. The E. Coli bacteria pallet was then collected by centrifuging at 10k
rpm for 3 minutes. The plasmid of the bacteria was extracted using QIAprep® Miniprep kit and
sent for sequencing in DNA core facility at Georgia State University. Meanwhile, the PCR
product of the selected pool was also sent for next-generation sequencing (Core Facilities at the
University of Florida).

47

1.3.7.7 Synthesis of potential single-stranded aptamer candidates
The sequences of the highest abundance from the sequencing data were selected as the
top aptamer candidates. The sequences were synthesized using phosphate-modified
complementary template (5-phosphate C3UB2, 5'-phosphate-TGG TGC GAA TTC TGA AGG
GTG CCG CCA CCT CCC CCG CCT TAT GCT CGG TCC ACC CGG CCC ACG AAG GCA
GAC AAC GAA GG-3'), FAM-labeled sense primer 1 and TCO-TTP through similar PCR
procedures. The product mixture was purified using Millipore Amicon 10 kDa spin column. The
double strand was then incubated with lambda exonuclease for 4 hours at 37 °C to remove the
phosphorylated strand. The remained single-stranded TCO-modified DNA (500 µL) was further
reacted with 1mM BBA4 (25 µL) at r.t. for 1 hour. The boronic acid-modified product mixture
then purified with spin column.
1.3.7.8 Binding studies of aptamer candidates to cells
The binding affinity was measured using fluorescence from FAM-labeled sequences by
flow cytometry. 2 μM stock solution of selected sequences was prepared. Series diluted stock
solution to 31.25 nM. HPAF II cells were dissociated with trypsin. Cells were washed with
SELEX washing buffer and incubated with various concentration of sequences in 50 μL of
binding buffer. After 30 minutes incubation, cells were washed and re-suspended with washing
buffer, and further analyzed by flow cytometer.
1.4

Conclusion
A fast and efficient approach of post-PCR DNA modification is described. The modified

TTP (TCO-TTP) has a click handle for reaction with tetrazine, which can be used for tethering
other functional groups. Compared to previously reported methods, the approach described uses
a very fast click reaction and has the advantage of significantly improved reaction kinetics. The
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incorporation of a boronic acid functional group or a fluorophore has been described after the
successful incorporation of TCO-TTP. The boronic acid-labeled DNA can be used for aptamer
selection against carbohydrates and glycoproteins, while the fluorophore-labeled DNA can be
used for cell labeling studies among other applications. Following labeling work, boronic acidmodified aptamers that can selectively target HPAF II cell line was successfully selected and
examined. Taking advantage of high binding affinity between boronic acid and glycoproteins,
the selection efficiency is highly improved and selection rounds are decreased. This approach
provides an efficient way to generated aptamer for glycoprotein on cell surface. In addition, the
trans-alkene functional group in the modified DNA can also be used to tether other functional
group for various purposes.
1.5

Statements
The much of the results described in this chapter has been published in Org. Biomol.

Chem (Wang, K.; Wang, D.; Ji, K.; Chen, W.; Zheng, Y.; Dai, C.; Wang, B., Post-synthesis
DNA modifications using a trans-cyclooctene click handle, Org. Biomol. Chem. 2015, 13 (3),
909-915, DOI: 10.1039/C4OB02031F) and Curr. Org. Chem. (Wang, K.; Wang, D.; Wang, B.,
Modified nucleosides that can be incorporated into DNA enzymatically or in live cells, Curr.
Org. Chem. 2015, 19 (11), 1011-1020, DOI: 10.2174/138527281911150610101141). In this
chapter, my contributions include the synthesis of trans-cyclooctene-modified thymidine
triphosphate (TCO-TTP), enzymatically incorporation of modified thymidine into DNA
molecules through PCR, fluorophore and boronic acid functional groups labeling of DNA,
aptamer-cell binding studies and partially on aptamer selection and cloning process.
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2

DEVELOPMENT OF FLUORESCENT CHEMOPROBES FOR MOLECULES OF
BIOLOGICAL IMPORTANCE

2.1

Development of fluorescent chemoprobes for hydrogen sulfide (H2S)
2.1.1

Introduction

The past decade has seen a boost of research interest in hydrogen sulfide (H2S), which
has been recently recognized as one of the three important gasotransmitter, including nitric oxide
(NO)177 and carbon monoxide (CO).178 H2S is synthesized endogenously in the cell by enzymes
such as cystathionine β-synthase (CBS)179 and cystathionine γ-lyase (CSE).180 And it is involved
in the regulations of a series of important genes. Endogenous concentrations of H2S is related to
a number of diseases such as Down syndrome181 and lung diseases.182 H2S was also found to
show protective effects in the cardiovascular (CV)183 and central nervous systems (CNS)184 and
to play a regulatory role in inflammation.185-186 Regulation of H2S levels is also a potential drug
development strategy.187-188 The importance of accurate detection of H2S has been greatly
emphasized. However, this is not a trivial issue mainly due to the low stability of this gaseous
molecule. H2S is volatile and prone to oxidation. Considering the features of hydrogen sulfide,
such as reducing ability and duo-nucleophilicity (can undergo nucleophilic addition or
substitution twice), current detection for hydrogen sulfide uses either sulfide specific
chemosensor (methylene blue method),189 electrochemical methods (sulfide selective electrodes
or polarographic methods)190-191 and gas chromatography (GC).192 However, none of these
methods is compatible with detection and imaging in cells. These methods also show problems
such as narrow linearity ranges (methylene blue method) and complicated sample preparations
(chromatography). Fluorescent probes are emerging as important tools for the selective and
sensitive detection of H2S.193-195 Chang and our group first reported that the reduction of an azido
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group attached to a fluorophore could be utilized for the design of H2S-selective fluorescent
probes.196-197 Recently, a number of fluorescent probes have been developed, including probes
based on nucleophilic cyclization,198-202 redox reactions,197, 203-206 and metal-sulfide formation.207209

A few reviews have been published discussing H2S probes.210-213 Some recently published

probes are discussed below (Table 2.1).
Table 2.1 Properties of hydrogen sulfide probes
Wavelength (λex/

Reaction

Tempera

λem, nm) or Abs.

time (min)

ture (⁰C)

pH

Medium

LOD

biological system

NHS

450/ 555

20

37

7.4

ACN/ PBS 1: 9

0.48 uM

serum and live cells

CouMC

475/ 510& 652

0.5

r.t.

7.4

2% DMSO-PBS

1 uM

live cells

probe 40

450/ 485& 690

0.17

r.t.

7.4

ACN/ PBS 1: 3.3

0.14 uM

live cells

35

37

7.4

HEPES

5-10 nM

live cells

Probe

Application in

Lyso-

510& 700/ 625&
HS-Cy

780
350/ 440, 510, &

DMSO: phosphate

probe 46

570

30

37

7.4

buffer 2: 8

10 uM

live cells

SFP-1

300/ 395

60

37

7.4

PBS

5-10 uM

live cells

SFP-2

465/ 510

240

37

7.0

PBS

6 uM

live cells

SFP-3

500/ 525

30

25

7.4

PBS

1.5 uM

plasma

SF4

496/517

60

25

7.4

HEPES

125 nM

live cells

SF5-AM

498/521

60

25

7.4

HEPES

250 nM

live cells

SF7-AM

498/526

60

25

7.4

HEPES

500 nM

live cells

SHS-M1

365/500

90

r.t.

7.4

HEPES

200 nM

live cells, tissue

SHS-M2

383/545

90

r.t.

7.4

HEPES

400 nM

live cells, tissue

BOD

460/ 510

30

r.t.

7.4

PBS/ACN

<10 µM

live cells

probe 68

440/544

180

r.t.

7.4

Phosphate buffer

500 nM

live cells

MPhSe-
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2.1.1.1 Probes based on nucleophilic reactions
In aqueous solution, H2S dissociates to form nucleophilic anion HS-, which can react with
a variety of electrophiles. Taking advantage of this feature, a number of probes have been
developed. One of the examples is reported by Cui and co-workers with specific subcellular
localization property214 (Figure 2.1). This lysosome-targetable probe Lyso-NHS consists of a
1,8-naphthalimide fluorophore, a 4-(2-aminoethyl)morpholine moiety (the lysosome targeting
group), and a dinitrophenyl ether as the H2S reactive site.

Figure 2.1 Structure of probe Lyso-NHS and its mechanism of action

Among all fluorescent probes, ratiometric probes afford easy quantification due to the
advantage of self-calibration. In 2013, Z. Guo and co-workers reported a ratiometric H2S probe
CouMC (Figure 2.2), for detection in mitochondria.215 The selectivity for H2S over Cys, Hcy and
GSH is achieved due to differences in pKa values. Biothiols have a higher pKa (> 8.5)216 than
H2S (7.0), which makes H2S a better nucleophile in neutral medium. Another ratiometric
fluorescent probe flavylium derivative (compound 40) was reported by W. Guo and co-workers
recently (Figure 2.2).217 With a similar strategy, this probe featured a fast detection response (<
10 s) and NIR property (λem: 485 and 690 nm) in ACN/PBS (1: 3.3). MTT cytotoxicity studies
using HeLa cells showed 80% cell viability after incubation with 10 µM probe for 24 h.
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Further increased sensitivity was achieved by a NIR probe HS-Cy reported by the Tang
group (Figure 2.2)218 This probe takes advantage of the duo-nucleophilicity of hydrosulfide
anion. It undergoes a nucleophilic addition by sulfide, followed by a thiolactone formation
releasing a cyanine fluorophore.

Figure 2.2 Structure of ratiometric H2S probes and their mechanisms of actions

A white light-emitting fluorescent probe (46) reported by Lin and co-workers shows
advantages of low-background multi-channel detection (Figure 2.3).219 This probe was
constructed by conjugating a blue fluorescent dye and with an ESIPT (excited-state
intramolecular proton transfer) dye, which is modified by a 2,4-dinitrophenyl group as the
reactive site. This probe can be utilized to detect endogenous H2S in living cells with threechannel monitoring. Although this probe is not as sensitive as some aforementioned probes, it
features a new multi-channel sensor for hydrogen sulfide.
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Figure 2.3 Structure of probe 46 and its mechanism of action

A series of hydrogen sulfide probes (SFP1, 2, 3, Figure 2.4) were reported by the He
group.220-221 Based on a Michael addition-cyclization mechanism, these probes (5-10 µM)
selectively react with sulfide exhibiting more than 10-fold fluorescence increases. Furthermore,
SFP-1 and SFP-2 can be applied in dynamic monitoring of enzymatic hydrogen sulfide
biosynthesis.
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Figure 2.4 Structures of SFP probes and its mechanism of action
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2.1.1.2 Probes based on redox reactions
In 2013, Chang and co-workers reported several bis-azido rhodamine analogues (SF4SF7, Figure 2.5) for cell imaging of hydrogen sulfide.222 Compared to the mono-azido probes
reported in 2011, these bis-azido analogues exhibit improved sensitivity with detection limits
ranging from 125-500 nM. Acetoxymethyl esters (SF5-AM, SF7-AM, etc.) were synthesized to
provide cell-trappability for increased imaging sensitivity by maintaining a high dye
concentration in the cells. Production of H2S was observed in HUVECs (human umbilical vein
endothelial cells) using SF7-AM and it was found that H2S generation is dependent on NADPH
oxidase (Nox) derived H2O2, providing evidence in support of H2S/H2O2 crosstalk.
Ratiometric two-photon excitation fluorescent probes SHS-M1 and SHS-M2 (Figure 2.5)
were reported recently by Kim and co-workers.223 The reduction of the 4-azidobenzyl group to
the corresponding aniline triggers the cleavage of the carbamate, releasing the N-methylaniline
analogues and resulting in a red shift from 420 to 500 nm for SHS-M1 and 464 to 545 nm for
SHS-M2. This shift in emission provides feasibility for ratiometric detection of hydrogen sulfide
for cellular imaging. The positively charged TPP serves as a mitochondria-targeting moiety.
SHS-M2 was used to monitor H2S in cultured astrocytes and showed that H2S production
decreased when CBS was knocked down by siRNA. It was also found that H2S level decreased
in DJ-1-knockout astrocytes and brain slices as Parkinson’s disease models.
A selenium-bearing fluorescent probe (MPhSe-BOD, Figure 2.5) was reported by Han
and co-workers.224 It exhibits a reversible redox cycle between oxidation by hypochlorous acid
(HClO) to MPhSeO-BOD (strongly fluorescent) and reduction by H2S back to the original probe
(weakly fluorescent). In a confocal imaging experiment, this probe showed good cell
permeability in murine macrophage cell RAW264.7. It also showed the ability to continuously
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monitor the HClO/H2S redox cycles when the production of hypochlorous acid (HClO) in cells
was stimulated by phorbol myristate acetate (PMA) or exogenous sulfide was added into the cell
culture. Similar strategy was also used in a NIR fluorescent probe reported by the same group.225
Another redox-sensitive naphthalimide-based fluorescent probe 68(Figure 2.5) was
reported recently by Wang and co-workers.226 The reduction of hydroxylamine moiety by H2S
led to the production of its amino analogue as well as a dramatic increase in fluorescence
intensity. A detection limit of sub-micromolar concentration was achieved. Imaging experiments
in astrocytes using this probe revealed good cell membrane permeability. However, the slow
kinetics (reaction requires 180 min to finish) hampers imaging applications. A fluorescent
protein (FP)-based hydrogen sulfide probe cpGFP-Tyr66pAzF was recently reported by the Ai
group.227

56

Figure 2.5 Structure of redox-based H2S probes and their mechanism of action

2.1.2

Results and discussion

The redox-based fluorescent probe (DNS-Az), which was reported by our group, shows
significant fluorescence “turn-on” effect in the presence of H2S in aqueous solutions. Most
importantly, the sensing reaction (completes in minutes) is the fastest among all redox-based
fluorescent probes for H2S. This might be attributed to the unique structure features of DNS-Az.
Compared to other redox-based fluorescent probes bearing an azido group, DNS-Az includes a
sulfonyl azide. We believe that the sulfonyl azide provides the probe with fast reaction rates and
increased photo-stability. However, the quantum yield of the fluorescent species DNS-NH2 is
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very low (< 0.05) in pure aqueous solutions. In order to reach higher sensitivity, a surfactant
Tween-20 was added in previous experiments.196 Herein we describe the synthesis and
evaluation of a new fluorescent probe, which shares structure similarity with the previously
reported probe but emits a different wavelength with higher fluorescence quantum yield and
detection sensitivity in phosphate buffer without addition of any surfactant.
The structure of DNS-Az is based on a 1,5-dansyl fluorophore, which is known for its
large Stokes shift (λex = 330 nm, λem = 517 nm in phosphate buffer/Tween-20). 2,6-Dansyl
fluorophore has a smaller Stokes shift, however exhibits much higher fluorescence quantum
yield in pure aqueous media.228 Therefore, it is conceivable that 2,6-dansyl azide (2,6-DNS-Az,
73) might serve as a fluorescent probe for H2S with high detection sensitivity in pure aqueous
media. Starting from commercially available 6-amino-2-naphthalenesulfonic acid (70), 2,6dansyl azide was synthesized in 3 simple steps, including reductive alkylation to form
dimethylamino sulfonate 71, formation of sulfonyl chloride 72, and substitution with sodium
azide to afford the sulfonyl azide 73 in 35% overall isolated yield.

Scheme 2.1 Synthesis of 2,6-dansyl azide

2,6-Dansyl azide was evaluated as a fluorescent probe for H2S. In all experiments, Na2S
was used as the sulfide source in aqueous solutions as reported previously196 and elsewhere. As
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expectedd, 2,6-DNS
S-Az could bbe easily redduced to itss correspondding sulfonyyl amide aft
fter sulfide
additionn. 2,6-Dansyyl amide 744 was isolatted and idenntified usingg 1H NMR,,

13

C NMR and mass

spectrom
metry (see appendix). The quantu
tum yield oof 2,6-dansyyl amide 744 was abouut 40-fold
higher tthan that off 1,5-dansyl amide in ddeionized water (see exxperimental section). Inn a sulfide
detectioon experimeent, 20 μM of probe 733 showed ann over 100--fold fluoresscence increease in 60
min afteer addition of only 100 μM of sullfide in phoosphate buff
ffer without surfactant. This is a
much more
m
significant changee comparedd to the 8-ffold fluoresccence increease observeed for the
first-genneration proobe 1,5-DNS
S-Az in phoosphate bufffer (Figure 22.7b).
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Blue linne representts fluorescennce response of 2,6-DN
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fide (10 µM
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uorescence rresponse of 22,6-DNS-Az (20 µM) to hydrogen su
ulfide (10
µM
M) in 0.1 M phosphate b
buffer (pH =7.4).
=

A stockk solution off 2,6-DNS-A
Az (10 mM in acetonitrrile, 2 µL, ffinal concenntration 1000 µM) was
added innto 1.0 mL of a solutioon containinng 10 µM of
o Na2S. Thhen it was m
mixed thorouughly and
placed iin a fluorom
meter for m
measurementts with λEx= 325 nm att a series off time poinnts for 120
min (sam
mple was noot exposed tto UV between these tim
me points)

Fluoroscence Response
p

600
500
400
300
200
100
0
0

50

100

150

min)
Time (m

Figure 22.9 Reaction
n time profilee of 2,6-DNS
S-Az (20 µM
M) in the pressence of hyd
drogen sulfid
de (10 µM)
in 0.1 M ph
hosphate bufffer (pH =7.44).

Fluorescence intensityy at 445 nm w
was plotted against tim
me.
A
After
the fluuorescence response off 2,6-DNS-A
Az to sulfidde was demoonstrated, a variety of
17 com
mmon anionss, includingg sulfur-conntaining redducing anionns, were ussed at conccentrations

60

above their physiological levels, to test the selectivity of 2,6-DNS-Az. It was found that 2,6dansyl azide showed almost exclusive response to sulfide over other anions. For strong reducing
anions such as HSO3-, S2O42-, and S2O52-, the selectivity was found to be 30 to 44-fold. Other
reducing biological species, such as cysteine (Cys) and glutathione (GSH) at 100 μM, were also
tested (Figure 2.10). The probe did not show fluorescence response to Cys and GSH. A slight
increase in fluorescence response to sulfide was found in the presence of Cys and GSH. This
could be due to antioxidative effect of Cys and GSH, which prevented undesired oxidation of
sulfide in the reaction media. Selectivity over nucleophilic species was also tested by using high
concentrations (1 mM) of glycine and lysine. These results have indicated that 2,6-DNS-Az
shows sufficient selectivity for the detection of H2S in a complex biological sample.
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Figure 2.10 Fluorescence changes of 2,6-DNS-Az (20 μM) in the presence of (sulfide and) various
anions.

a. Fluorescence changes of 2,6-DNS-Az (1) in the presence of various anions; b. fluorescence
changes of 2,6-DNS-Az (1, 20 μM) in the presence of sulfide and various anions (HS- 10 μM;
HSO3-, S2O42-, and S2O52- 20 μM; all other anions 1 mM in 20 mM sodium phosphate buffer (pH
7.4), λex= 325 nm). Anions tested: Cl-, Br-, I-, F-, OH-, OAc-, CN-, N3-, NO2-, NO3-, HCO3-, HSO3-

61

, SO42-, S2O32-, S2O42-, S2O52-, and citrate. Data represents average of three independent
experiments.
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Figure 2.11 Fluorescence response of 2,6-DNS-Az to sulfide in the presence and absence of reducing
agents.

Fluorescence response of 2,6-DNS-Az to sulfide in the presence and absence of reducing agents
(cysteine 100 µM, GSH 100 µM) and nucleophilic amino acids (lysine 1 mM, glycine 1 mM) in
0.1 M phosphate buffer (pH =7.4).
For all quantitative analytical methods, a linear calibration curve is always preferred
because it allows easy calculation. After confirming the selectivity of 2,6-DNS-Az, this probes
was evaluated for quantitative measurement of H2S by testing concentration-dependent response
of 2,6-DNS-Az to sulfide. As shown in Figure 3, a linear correlation (R2 = 0.9993) was found
for sulfide in phosphate buffer. As determined by 3:1 signal/noise ratio, the detection limit for
sulfide in phosphate buffer is 1 μM (Figure 2.12). This indicates that 2,6-DNS-Az could be used
for quantitative measurement of H2S in pure aqueous media.
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Figure 2.12 Hydrogen sulfide concentration dependent fluorescence intensity changes.

2,6-dansyl azide 20 μM, Na2S 0-10 μM in 100 mM phosphate buffer (pH 7.4, λex= 325 nm), Data
represents average of three independent experiments.
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Figure 2.13 Measurement of LOD.

Red line represents fluorescence response of 2,6-DNS-Az (20 µM) to sulfide (1.0 µM). Blue line
represents the background fluorescence of 2,6-DNS-Az (20 µM) in 0.1 M phosphate buffer (pH
=7.4).
Due to the biological significance of H2S, the detection of H2S in biological systems such
as blood serum is of great importance in both research and clinical applications. Therefore, we
are also interested in using 2,6-DNS-Az for sulfide detection in serum. The probe was evaluated
in fetal bovine serum (FBS). First, a reaction time profile was tested for 2,6-DNS-Az and sulfide.
As shown in Figure 2.14, although FBS shows some background fluorescence, a very significant
increase was still observed after addition of sulfide. Over 10-fold fluorescence increase was
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observed for only 10 μM of sulfide. This indicates more than 2-fold higher sensitivity compared
to 1,5-DNS-Az reported earlier by our group. The reaction of 2,6-DNS-Az with sulfide is very
fast and completes in about 2 minutes in FBS. This is very promising considering that H2S is
very unstable and easily consumed in biological systems. We also tested concentrationdependent fluorescence changes of 2,6-DNS-Az in FBS. The linear calibration curve (R2 =
0.995) obtained in FBS has also indicated that 2,6-DNS-Az could serve as a useful tool for H2S
detection. The detection limit of H2S in FBS is about 6 μM.
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Figure 2.14 Reaction time and concentration dependent profile of 2,6-DNS-Az (20 μM) and H2S (10
μM) in FBS

a. Reaction time profile of 2,6-DNS-Az (20 μM) and H2S (10 μM) in FBS; b. H2S concentration
dependent fluorescence intensity changes, determined using a fluorometer: 2,6-DNS-Az 20 μM,
Na2S 0-10 μM in FBS (λex= 325 nm). Concentration dependence data represents average of three
independent experiments.
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2.1.3

Experimental Section

2.1.3.1 General Information
Solvents and reagents were purchased from VWR International, Oakwood Product Inc.,
or Sigma-Aldrich Co., and used without purification unless specified otherwise. When necessary,
solid reagents were dried under high vacuum. Reactions with compounds sensitive to air or
moisture were performed under argon. Solvent mixtures are indicated as volume/volume ratios.
Thin layer chromatography (TLC) was run on Sorbtech W/UV254 plates (0.25 mm thick), and
visualized under UV-light or by a Ce-Mo staining solution (phosphomolybdate, 25 g;
Ce(SO4)2.4H2O, 10 g; conc. H2SO4, 60 mL; H2O, 940 mL) with heating. Flash chromatography
was performed using Fluka silica gel 60 (mesh size: 0.040-0.063 mm) using a weight ratio of ca.
30:1 for silica gel over crude compound. 1H and

13

C-NMR spectra were recorded on a Bruker

400 spectrometer (400 and 100 MHz, respectively) in deuterated chloroform (CDCl3), methanold4 (CD3OD), or DMSO-d6 with either tetramethylsilane (TMS) (0.00 ppm) or the NMR solvent
as the internal reference. UV-Vis absorption spectra were recorded on a Shimadzu PharmaSpec
UV-1700 UV-Visible spectrophotometer. Fluorescence spectra were recorded on a Shimadzu
RF-5310PC spectrofluorophotometer. 96-Well plates were read and recorded on a PerkinElmer
1420 multilabel counter.
2.1.3.2 Synthesis and Characterization
6-(Dimethylamino)naphthalene-2-sulfonic acid 71: To a solution of compound 70 (220
mg, 0.99 mmol) in acetonitrile (3 mL), formaldehyde (1 mL) was added dropwise. After the
reaction mixture was stirred for 10 min, NaCNBH3 (450 mg, 7.2 mmol) was added in 2 portions.
Then, AcOH (1 mL) was added in 4 portions during 4 h. The reaction was stirred at r.t. for an
additional 2 h. The product precipitated out from the reaction solution. The white precipitate was
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filtered out, washed with H2O and MeOH, and dried (225 mg, yield: 91%). 1H NMR (CD3OD): δ
8.17 (1H, s), 7.79 (1H,d, J = 8.8 Hz), 7.75 (1H, d, J = 8.8 Hz), 7.69 (1H, d, J = 8.4 Hz), 7.28
(1H, d, J = 8.8 Hz), 7.00 (1H, s), 3.08 (6H, s); MS (ES+) 252.1 (M+1)+.
6-(Dimethylamino)naphthalene-2-sulfonyl azide 73: To an Ar-protected solution of 71
(225 mg, 0.9 mmol) in POCl3 (1.1 mL) in an ice bath, PCl5 (832 mg, 4 mmol) was added in one
portion. The reaction mixture was stirred at 0 oC for 2 h. Then, the reaction was stirred at r.t. for
an additional 2 h. The reaction mixture was poured into 100 g ice and the product was extracted
with EtOAc (100 mL × 3). The organic phase was dried over Na2SO4, and concentrated under
vacuum to yield crude product 72. The crude product 72 was dissolved in THF (5 mL) and added
into a stirred solution of NaN3 (580 mg, 9 mmol) in a 1:1 mixture of THF/H2O (10 mL). The
reaction mixture was stirred at room temperature for 2 h. Organic solvent was evaporated to
obtain light yellow solid. The crude product was purified by flash chromatography purification
(Hex: EtOAc, 20: 1) to give compound 73 as light yellow solid (134 mg, 54%). 1H NMR
(CDCl3): 8.33 (1H, s), 7.82 (1H, d, J = 9.2 Hz), 7.72 (2H, s), 7.24 (1H, t, J = 9.2 Hz), 6.88 (1H,
s), 3.14 (6H, s);

13

C NMR (CDCl3): 151.0, 138.0, 130.7, 129.6, 127.5, 124.2, 122.5, 117.2,

104.9, 40.3; IR 2133, 1614 1507, 1361, 1069, 840, 812, 739; MS (ES+) 277.1 (M+1)+.
6-(Dimethylamino)naphthalene-2-sulfonamide 74: To a stirred solution of 2,6-DNS-Az
(19.8 mg, 0.072 mmol) in 1.44 mL acetonitrile was added dropwise a solution of Na2S (51.6 mg,
0.22 mmol) in H2O. The solution was stirred at r.t. for 30 min and was dried under vacuum. The
crude product was purified by column chromatography to give compound 74 as white solids (13
mg, 72%). 1H NMR (DMSO-d6, 400 MHz): 8.18 (1H, s), 7.90 (1H, d, J = 9.2 Hz), 7.78 (1H, d, J
= 8.8 Hz), 7.68 (1H, d, J = 8.8 Hz), 7.31 (1H, d, J = 9.2 Hz),7.24 (2H, s), 6.99 (1H, s), 2.50 (6H,
s); MS (ES+) 251.08 (M+1)+.
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2.1.3.3 Relative quantum yield determination of 2,6-DNS-Az and 2,6-DNS-NH2
1,5-DNS-NH2 was used as the reference for relative quantum yield determination.
Absorption and emission (λEx= 325 nm) spectra were recorded for a series of concentrations (16
µM, 12 µM, 8 µM, 4 µM and 0 µM in deionized water) of 1,5-DNS-NH2, 2,6-DNS-NH2, and
2,6-DNS-Az. Integrated fluorescence intensity was plotted against the absorption values at each
concentration (Figures 2.15 and 2.16).229 Relative quantum yield values can be calculated using
slopes of each compound.
18000
y = 1,470,647x
R² = 1

Integrated Fluorescence Intensity

16000

2,6-DNS-Az

14000

2,6-DNS-NH2

12000
10000
8000
6000
4000

y = 17636x
R² = 0.9588

2000
0
0

0.005

0.01

0.015

0.02

0.025

0.03

Abs.

Figure 2.15 Quantum yield determination of 2,6-DNS-Az (0-20 µM) in H2O
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Figure 2.16 Quantum yield determination of 1,5-DNS-NH2 (0-20 µM) in H2O
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2.1.4

Conclusions
The biological significance as well as difficulty in accurate detection of H2S urged

chemists to find new detection methods. We have reported previously a fluorescent probe (1,5DNS-Az) for H2S detection, but requires the addition of Tween-20 to achieve sufficient
sensitivity when used in buffer solutions. The present work reports the development and
evaluation of a new fluorescent probe for H2S, 2,6-DNS-Az. This probe shows much higher
fluorescence change in pure aqueous media (>100-fold for 10 µM of sulfide) compared to the
probe described earlier (8-fold) without addition of any surfactant. High detection sensitivity,
almost exclusive selectivity and excellent linear correlation for sulfide in aqueous solution and
blood serum make this probe a useful tool for quantitative detection of H2S.
2.1.5

Statements
The much of the results in this chapter has been published in J. Fluoresc. (Wang, K.*;

Peng, H.*; Ni, N.; Dai, C.; Wang, B., 2,6-Dansyl azide as a fluorescent probe for hydrogen
sulfide. J. Fluoresc. 2014, 24 (1), 1-5, DOI: 10.1007/s10895-013-1296-5) and J. Cell. Biochem.
(Wang, K.; Peng, H.; Wang, B., Recent advances in thiol and sulfide reactive probes. J. Cell.
Biochem. 2014, 115 (6), 1007-1022, DOI: 10.1002/jcb.24762). In this chapter, my contributions
include fluorescence studies and quantitative determination of hydrogen sulfide probe.
2.2
2.2.1

Development of fluorescent chemoprobes for homocysteine (Hcy)
Introduction
Thiols, such as cysteine (Cys), homocysteine (Hcy) and glutathione (GSH) (Figure 2.17),

are indispensable functional molecules in the biological system due to the strong nucleophilicity
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and redox reactivity of the sulfhydryl group.230 Thiols are ideal nucleophiles in enzyme
functions, excellent sensors231 and mild buffering molecules for maintaining cellular redox
states.232-233 Biological thiols play versatile roles in various processes, including protein structure
and functions, antioxidant activity, and redox signaling. Hcy is a key intermediate generated
during the biosynthesis of Cys.234-235 Plasma Hcy exists in three major forms including free
reduced (~1%), free oxidized (30%) and protein-bound oxidized (70%) forms.236-237 Fluctuations
in thiol concentrations can indicate or even lead to a variety of cardiovascular disorders and
neurodegenerative diseases. For example, circulating Hcy has been correlated with Alzheimer’s
disease238 and coronary artery diseases,239-240 Excessive amount of total Hcy (tHcy) in the
blood,241 hyperhomocysteinemia (HHcy), is related to folate deficiency, which can lead to
miscarriage242 and various tumors.243 According to the American Heart Association (AHA)
advisory statement, normal tHcy concentrations range from 5-15 µM; moderate, intermediate,
and severe hyperhomocysteinemia refer to concentrations between 16 and 30, between 31 and
100, and >100 µM, respectively, and are essentially pathognomonic.244 Cys deficiency is
associated with slow growth, and liver and skin damage.245 High Cys concentration exhibits
neurotoxicity.246 Decrease in GSH concentration was also shown to be associated to Parkinson’s
disease.247 As a result, accurate determination of these biological thiols, especially of Hcy in
biological systems such as blood plasma and urine are of great importance in both clinical and
research practice.

Figure 2.17 Structures of Cysteine (Cys), Homocysteine (Hcy) and Glutathione (GSH)
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By taking advantage of the unique chemical properties of the sulfhydryl group, such as
strong nucleophilicity and low redox potential (-0.2~-0.3 V),248-249 general detection of thiols can
be achieved using thiol reactive probes and electrochemical probes.250 For determination of
specific thiols, both detection methods can be coupled with different separation technology, such
as chromatography and capillary electrophoresis (CE). Chemically derivatized thiols can also be
selectively detected using mass spectrometry (MS). Due to the low redox potential of the
sulfhydryl group, thiols (R-SH) are readily oxidized to their disulfide state. For example, more
than 95% of total Hcy is in the oxidized form,251 while only a very small amount is in the form of
free thiol. Therefore, a reducing pre-treatment is usually required to convert all thiol species to
their reduced forms before analysis of total thiol concentrations. Reducing agents such as
dithiothreitol (DTT), tris(2-carboxyethyl)phosphine (TCEP),252 or sodium borohydride (NaBH4)
can be used for the reduction of disulfide bonds. Because the chemical derivatization relies on
the nucleophilicity of the sulfhydryl group (pKa of –SH in cysteine:253 8.15, Hcy: 8.7, GSH:
8.56), pH of the media is also an important factor affecting the reaction rates and outcomes.
Basic buffer condition is often used to deprotonate sulfhydryl group and to accelerate the sensing
reaction.254-255 For thiol reactive probes, numerous reaction types have been utilized, including
nucleophilic substitution, Michael addition, cyclization, and cleavage of disulfide bond, metal
complexes coordination, and redox reactions.
Normal tHcy is lower than 15 µM in plasma, which is about 1/20 of the total Cys
concentration.251 Due to high degree of similarity in both structure and chemical properties
between Hcy and other thiols such as Cys, the selective detection of Hcy has never been a trivial
issue. Current detection methods for Hcy involve the derivatization at the sulfhydryl group using
electrophilic fluorogenic reagents.256-258 However, due to the lack of selectivity among different
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biological thiols, these methods require tedious separating techniques such as GC and HPLC.
This has led to an increased cost and reduced efficiency and thus limited the applicability of Hcy
as an important biomarker. Therefore, selective recognition of Hcy over other biological thiols is
of great interest. In this and the following sections, Cys/Hcy-specific probes, and Hcy -specific
probes (Table 2.2) are discussed.
Table 2.2 Properties of Cys and Hcy probes
Probe

Analyte

CIC

Cys/ Hcy

Wavelength (λex/

Reaction

Tempera

λem, nm) or Abs.

time (min)

ture (oC)

430/547

30

37

pH

Medium

LOD

Application in
biological system

7.2

DMSO:

N.D.

N.D.

HEPES 9: 1
MV2+

Hcy

510 (Abs.)

5

r.t.

7.5

Tris

N.D.

plasma

fluorone

Hcy

510 (Abs.)

5

r.t.

7.3

phosphate

N.D.

plasma

4.4 nM

plasma

black
FSN-

buffer
Hcy

370/ 485

AuNPs

120

r.t.

13

phosphate
buffer

Tris: tris(hydroxymethyl)aminomethane

In 2010, Li reported an inorganic phosphorescent imaging probe, cationic iridium (III)
complex (CIC) (Figure 2.18), for Cys and Hcy detection in living cells.259 Upon addition of
aminothiols, the probe’s luminescence changes from yellow to red in DMSO-HEPES (9: 1). This
makes it a “naked-eye” indicator of Cys or Hcy. With its membrane-permeable property, CIC
can ratiometrically indicate the intracellular Cys and Hcy concentrations.
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Figure 2.18 Structures of Cys/Hcy-specific probes and their mechanisms

Two Hcy-specific probes based on redox chemistry were reported by the Strongin
group.255,

260

One visual detection probe was methyl viologen (MV2+) (Figure 2.19), which

responded to Hcy changing from colorless to blue in 5 min. Another commercially available
probe fluorone black (Figure 2.19) shared a similar mechanism as that of MV2+ with higher
detection sensitivity (linearity working range 0-15 µM).

Figure 2.19 Structures of Hcy-specific probes and their mechanisms of action

Another quantitative detection method of Hcy in plasma was reported by Tseng and coworkers in 2012.254 The combination of TCEP reduction, fluorosurfactant-capped gold
nanoparticles (FSN-AuNP) extraction and subsequent o-phthaldialdehyde (OPA) derivatization
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(Figure 2.20) provided a selective and sensitive method for quantification of total Hcy as well as
protein-bound, free, and free oxidized Hcy. To avoid the interference of Cys, particle size of
FSN-AuNPs was increased from 12 nm to 40 nm, which led to a higher aggregation rate of Hcyattached AuNPs than Cys-attached.261 In addition, OPA can selectively react with Hcy forming a
highly fluorescent (9-fold intensity increase) product emitting at 485 nm with excitation at 370
nm.262 Within the dynamic range 0.01-1 µM, the detection limit of this method was determined
to be 4.4 nM. This detection method can provide more than 100-fold selectivity toward Hcy over
other aminothiols in plasma. However, the detection pH of this probe was 13, which cannot be
widely used in detection in a biological system.

Figure 2.20 Schematic presentation of probe FSN-AuNPs assay and its mechanism of action

Fluorescent probes based on cyclization mechanisms using both the amino and sulfhydryl
groups have been reported mostly selective for Cys.263-267 The Strongin group found a
colorimetric method for selective Hcy detection based on a radical mechanism.268-271 They also
reported a fluorescent probe showing different reaction profiles for Hcy and Cys and thus their
simultaneous detection.264 The Yoon lab recently reported a pyrene-based fluorescent probe
functionalized with an aldehyde moiety selective for Hcy.272 Herein we report a redox-sensitive
fluorometric detection of Hcy using a dansyl azide analogue 1 (DN-2).
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2.2.2

Results and discussion
During our search for redox-sensitive fluorescent probes for H2S,273 we discovered a

dansyl-based fluorescent probe (DN-2) with selectivity towards Hcy over other biological thiols
such as Cys and GSH in aqueous media. It is well known that thiols show reducing ability and
help to maintain the redox states in biological systems. Redox reactions have been employed in
thiol detections. For example, Ellman’s reagent (5,5’-dithiobis-2-nitrobenzoic acid or DTNB)274
is widely used in the quantitation of sulfhydryl groups through the reductive cleavage of a
disulfide bond, which releases the chromogenic indicator. However, only a few studies have
been reported on the difference in reducing ability among thiols.275-276
Specifically, we have synthesized dansyl derivative 87 (DN-2) as a fluorescent probe.
The synthesis of DN-2 is accomplished in 3 steps from commercially available starting materials
(Scheme 2.2). The substitution reaction between 5-naphthol-1-sulfonate 84 and ethylene diamine
was followed by reductive amination, which installed three methyl groups on the amino
groups.277 Then the sulfonate was converted to sulfonyl chloride, which reacted quantitatively
with sodium azide to form the sulfonyl azide, DN-2 (87). This short and convenient synthetic
route has provided the probe in a 37% isolated yield.

Scheme 2.2 Synthesis of the fluorescent probe DN-2

Fluorescence spectroscopy was used to monitor the reaction between DN-2 and
biological thiols, Cys, Hcy, and GSH. As is shown in Figure 1, a significant fluorescence
increase (~25-fold) at around 517 nm was observed for Hcy. Such fluorescent changes are also
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readily visible to the naked eyes (Figure2.21, insert). However, with Cys and GSH, only 2 and 3fold fluorescence intensity change was observed, respectively. Spectroscopic (1H NMR,

13

C

NMR, and MS) identification of the product confirmed that the sulfonyl azide was reduced by
Hcy, forming the corresponding sulfonamide and homocystine (Scheme 2.3). The fluorescence
increase was due to the formation of highly fluorescent DA-2 (ΦFL (DN-2) = 0.007 and ΦFL (DA2) = 0.58 in acetonitrile, ΦFL (DN-2) = 0.02 and ΦFL (DA-2) = 0.29 in water, Figure 2.22).

Scheme 2.3 Sensing reaction of DN-2 with Hcy
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Figure 2.21 Fluorescence spectrum of DN-2 in the presence of different amino thiols.

Fluorescence spectrum of DN-2 in the absence and presence of different amino thiols; insert:
time dependent fluorescence emission (517 nm) of DN-2 in the presence of different Hcy and
Cys, and comparison of fluorescence intensity change with the addition of different amino thiols.
(DN-2 120 µM, amino thiols 100 µM in 100 mM sodium phosphate buffer at pH 7.4 with 10%
ethanol, fluorescence spectrum and pictures were recorded 1 h after the addition of thiols).
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Figure 2.22 Quantum yield determination of DN-2 and DA-2.

a. Quantum yield determination of DN-2 and DA-2 in acetonitrile; b. quantum yield
determination of DN-2 and DA-2 in water. 1,5-DNS-NH2 was used as the reference for relative
quantum yield determination. Absorption and emission (λEx= 325 nm) spectra were recorded for
a series of concentrations (16 µM, 12 µM, 8 µM, 4 µM and 0 µM in acetonitrile or deionized
water) of 1,5-DNS-NH2, DN-2 (1) and DA-2 (2). Integrated fluorescence intensity was plotted
against the absorption values at each concentration.229 Relative quantum yield values can be
calculated using slopes of each compound
Next we compared the reaction time profile of DN-2 to thiols. Specifically, DN-2 was
dissolved in the solution to a final concentration of 120 µM, while thiol concentrations were 100
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µM. The probe, DN-2 was only weakly fluorescent in solvent systems, including acetonitrile
(ACN), 100 mM sodium phosphate buffer at pH 7.4, and water. Immediately after the addition of
thiols, an initial small increase in fluorescence was observed for all species (Figure 2.21, left
inset). However, the fluorescent intensity quickly reached a plateau for Cys and GSH. For Hcy,
the fluorescence intensity reached a plateau at about 1 h point at a much higher level. The
selectivity for Hcy over Cys and GSH was found to be 8-12-fold. However, since GSH
concentration in plasma is as low as ~2 µM,278 one would not expect interference problem with
GSH.
To further test the feasibility of DN-2 as a fluorescent probe in a complex biological
system, the selectivity of DN-2 was tested among various amino acids in phosphate buffer with
10% ethanol (Figure 2.23). It was found that DN-2 did not respond to most amino acids. A
selectivity of over 45-fold was found among these amino acids at 100 µM. The reaction between
DN-2 and Hcy was carried out in the presence of various amino acids (100 µM) (Figure 2.23b)
in order to test how the presence of other amino acids affects the fluorescence response of DN-2
to Hcy. It was found that the fluorescence response of DN-2 to Hcy was elevated by ~40% in the
presence of 100 µM Cys. GSH showed similar effect. In contrast, none of the other amino acids
affected the detection of Hcy. In addition, other possible reducing species in biological samples,
such as Fe(II), Cu(I), and ascorbate, showed no reactivity with DN-2 (Figure 2.24)
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Figure 2.23 Fluorescence response of DN-2 to amino acids.

a. Fluorescence response of DN-2 to amino acids; b. fluorescence response of DN-2 to Hcy in
the presence of amino acids. (DN-2 120 µM, amino acids 100 µM in 100 mM sodium phosphate
buffer at pH 7.4 with 10% ethanol, fluorescence intensities were recorded 1 h after the addition
of amino acids. Data represents the average of three independent experiments.)
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Figure 2.24 Fluorescence response of DN-2 to metal ions

Fluorescence response of DN-2 to FeCl2, FeSO4, CuBr, CuCl, CuI, and ascorbic acid in
comparison with negative control (DN-2 alone) and positive control (Hcy addition to DN-2
solution). (DN-2 120 µM, analytes 100 µM in 100 mM sodium phosphate buffer at pH 7.4 with
10% ethanol, fluorescence intensities were recorded 1 h after the addition of reducing species.
Data represents the average of three independent experiments.)
A fluorescent probe is especially useful for quantitation if a linear calibration curve could
be obtained. Therefore, experiments were performed to obtain a calibration curve using a series
of concentrations for Hcy. As expected, a linear calibration curve with R2 >0.99 was obtained for
Hcy (Figure 2.25). This linearity is very important for quantitative analysis of Hcy.
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Figure 2.25 Calibration curve for Hcy.

DN-2 120 µM, Hcy 100 µM in 100 mM sodium phosphate buffer at pH 7.4, with 10% ethanol;
fluorescence intensities at 517 nm were recorded 60 min after the addition of Hcy. Data
represents the average of three independent experiments.
Since the presence of Cys was found to increase the fluorescence response of DN-2 to
Hcy by ~40%, we were interested whether endogenous Cys fluctuations (~200-250 µM) would
affect Hcy detection. In order to test the effect of Cys fluctuation, calibration curves of Hcy at 050 µM was generated in the presence of 200 and 250 µM of Cys (Figure 2.26). It was found that
these two curves are very close, though not identical. Therefore, the accuracy of Hcy quantitation
may be affected by Cys fluctuation. However, the selectivity of DN-2 to Hcy still allows a good
estimation of Hcy level with large (~50 µM) fluctuation of Cys concentrations.
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Figure 2.26 Calibration curve of homocysteine in the presence of 200 and 250 µM of cysteine.
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DN-2 120 µM, Hcy 0-50 µM in 100 mM sodium phosphate buffer at pH 7.4, with 10% ethanol;
fluorescence intensities at 517 nm were recorded 60 min after the addition of Hcy. Data
represents the average of three independent experiments.
As arylsulfonyl azide was found to be a very sensitive fluorescent probe for sulfide,258, 279
DN-2 also reacts with sulfide. In order to exclude the influence of sulfide in the selective
detection of Hcy, a solution of ZnCl2 could be added into the reaction buffer to precipitate
sulfide out of the solution in the form of ZnS (Ksp(ZnS)~2×10-25). It was found that the presence
of high concentration of Zn2+ (at 300 µM) shows very little interference with the fluorescence
response of DN-2 to Hcy (Figure 2.27).

Fluorescence Intensity

700
600
500
400
300
200
100
0
0

50

100

150

200

250

300

350

Zn2+ conc.

Figure 2.27 Fluorescence response of DN-2 to Hcy in the presence of different concentrations of
Zn2+

DN-2 120 µM, Hcy 100 µM in 100 mM phosphate buffer with 10% ethanol at pH 7.4.
Fluorescence was recorded on a fluorometer after reaction for 120 min in the presence of 0, 50,
100, 200 and 300 µM of ZnCl2, respectively. Data represents the average of three independent
experiments.
Due to the significance of Hcy in biological system, the application of this probe in serum
was examined. In diluted (10%) deproteinized fetal bovine serum (FBS), with addition of Hcy,
this probe selectively responded to Hcy over Cys (Figure 2.28, insert). Furthermore,
concentration-dependent fluorescence changes of DN-2 in diluted deproteinized FBS were
observed. A linear calibration curve (R2 = 0.9997) was obtained suggesting the potential utility
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of DN-2 in serum. The detection limit of Hcy in deproteinized FBS was 10 µM based on a 3-fold
signal-to-noise ratio.
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Figure 2.28 Calibration curve for Hcy

DN-2, 120 µM, Hcy, 0-100 µM in diluted deproteinized FBS, fluorescence intensities at 517 nm
were recorded 180 min after addition of Hcy. Data represents the average of three independent
experiments; Insert shows time-dependent fluorescence response of DN-2 (120 µM) to Hcy (100
µM) or Cys (100 µM) in diluted deproteinized FBS.
Our experiments have found that DN-2 selectively oxidizes Hcy in buffer and diluted
deproteinized FBS. Although Cys is reduced by DN-2 at very high concentrations (~100 mM),
there is apparently a large difference at lower concentrations. Thus, we were interested in
achieving an understanding of the difference in reducing ability between Cys and Hcy. Hcy has
one extra methylene group compared to Cys. However, this does not make its sulfhydryl group a
stronger nucleophile since most nucleophilic substitution-based fluorescent probes show similar
reactivity with both thiols. We have also examined the pKa of the sulfhydryl groups on Cys and
Hcy using pH titration.280 It was found that the pKa was 8.25 for Cys and 8.9 for Hcy (Figure
2.29), similar to most previously reported values.280-281 (In another paper, the pKa of –SH group
was reported to be as high as 10.282) According to these pKa values, Cys should be deprotonated
more easily than Hcy. Therefore, one would expect that Cys being a stronger reducing agent than
Hcy if pKa was the determining factor. Fluorescent/colorimetric probes with disulfide moieties
show comparative or slightly higher reactivity to Cys.283-284 This may be due to their difference
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in pKa. However, this is not the case in the redox reaction between these thiols and DN-2, where
a different mechanism is indicated. In fact, it has been reported that oxidation of Hcy by albumin
is faster than that of Cys and the oxidation is accelerated by basic conditions or addition of a
copper catalyst.276, 285
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Figure 2.29 Titration curves of cysteine and homocysteine.

a. Titration curve of 5 mM cysteine hydrochloride; b. Calculation of the sulfhydryl group pKa of
cysteine; c. Titration curve of 5 mM homocysteine hydrochloride; d. Calculation of the
sulfhydryl group pKa of homocysteine. NaOH solution (99.35 mM) was standardized with
potassium hydrogen phthalate (KHP) and used for titration of 5 mM cysteine hydrochloride and
5 mM homocysteine hydrochloride. Experiment was triplicated to obtain the average pKa values
(8.25 for cysteine and 8.9 for homocysteine).
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The reduction mechanism of an azido compound by a dithiol has been proposed in a
previous report.286 Based on the experimental results, we propose that the initial attack by thiol
leads to the formation of an intermediate 90 (Scheme 2.4), which is responsible for the initial 23-fold fluorescence increase. Proton transfer then occurs to neutralize the negatively charged
nitrogen leading to intermediates 89b and 89c. In the case of Hcy, the amino group then attacks
the sulfur to form a five-membered ring intermediate 7, which then reacts with another molecule
of thiol to form the disulfide product. The intermediate 90 then releases N2 to provide the
sulfonamide product 88. In the case of Cys, a similar intramolecular attack would lead to a
strained four membered ring 92, which would be unstable and thus unfavorable. In addition, the
reversibility of the initial step means that the intermediate (89) exists in equilibrium with the
starting materials and thus the probe (87) is available to react with Hcy even in the presence of
Cys. In fact, cyclic transition states/intermediates have been used to explain the mechanisms of
other Cys- or Hcy-selective probes.264,

268-269

It is entirely possible that there are other

conformational factors, which affect the reactivity of intermediate 89. In the last step, another
thiol comes to attack the sulfur to form a disulfide. Although gaseous diatomic bond energy for
general S-N bond is higher than S-S bond,287 the formation of disulfide bond from the attack of
sulfhydryl group on an electron-deficient S-N bond has been reported previously.288 In this step,
it is conceivable that when excessive amount of Cys exists in the reaction media, a Cys-Hcy
mixed disulfide could also form. This explains why Cys alone does not trigger fluorescence
increase but causes a ~40% increase in fluorescence response to Hcy. It should be noted that a
previously published dansyl azide analogue, 1,5-DNS-Az also shows selectivity for Hcy (Figure
2.30).
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Figure 2.30 Time dependent fluorescence emission (517 nm) of 1,5-DNS-Az in the presence of Hcy
and Cys

DNS-Az 120 µM, amino thiols 100 µM in 100 mM sodium phosphate buffer at pH 7.4 with 10%
ethanol
In addition, the influence of pH on the selectivity has also been tested using 96-well plate
and a microplate reader (Figure 2.31). Sodium phosphate buffer (100 mM) in the pH range of
5.3-11.5 was used in the experiments. A pH dependent fluorescence response was observed for
DN-2 in the presence of thiols. It was found that DN-2 itself remains fluorescently stable at pH
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values lower than 10.5. The selectivity for Hcy increased with increasing pH from 5-7.4. In
buffers at pH higher than 7.4, reactions with Cys and GSH were promoted. Therefore, the
highest selectivity was observed at pH 7.4, which is the physiological pH. We have also
examined the reaction time profile in phosphate buffer at 37 °C (Figure 2.32). The result has
suggested that heat facilitated the reaction. The reaction time for 120 µM of DN-2 and 100 µM
of Hcy decreased from 60 min at room temperature (about 22 °C) to 30 min at 37 °C.
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Figure 2.31 pH dependent fluorescence response of DN-2 to thiols.

Fluorescence intensity was read on a microplate reader (Excitation filter 340 nm, Emission filter
535 nm). DN-2 100 µM, thiols 100 µM in 100 mM sodium phosphate buffer at pH values of 5.3,
6.2, 7.0, 7.5, 8.3, 9.0, 10.5, and 11.5.
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Figure 2.32 Reaction time profile at 37 °C.

DN-2 120 µM, amino thiols 100 µM in 100 mM sodium phosphate buffer at pH 7.5, 37 °C,
fluorescence intensities at 517 nm were recorded at each time point
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2.2.3

Experimental section

2.2.3.1 General Information
Solvents and reagents were purchased from VWR International, Oakwood Product Inc.,
or Sigma-Aldrich Co. and used without purification unless specified otherwise. When necessary,
solid reagents were dried under high vacuum. Reactions with compounds sensitive to air or
moisture were performed under argon. Solvent mixtures are indicated as volume/volume ratios.
Thin layer chromatography (TLC) was run on Sorbtech W/UV254 plates (0.25 mm thick), and
visualized under UV-light or by a Ce-Mo staining solution (phosphomolybdate, 25 g;
Ce(SO4)2.4H2O, 10 g; conc. H2SO4, 60 mL; H2O, 940 mL) with heating. Flash chromatography
was performed using Fluka silica gel 60 (mesh size: 0.040-0.063 mm) using a weight ratio of ca.
30:1 for silica gel over crude compound. 1H and

13

C NMR spectra were recorded on a Bruker

400 spectrometer (400 and 100MHz, respectively) in deuterated chloroform (CDCl3), methanold4 (CD3OD), and DMSO-d6 with either tetramethylsilane (TMS) (0.00 ppm) or the NMR solvent
as the internal reference. UV-Vis absorption spectra were recorded on a Shimadzu PharmaSpec
UV-1700 UV-Visible spectrophotometer. Fluorescence spectra were recorded on a Shimadzu
RF-5310PC spectrofluorophotometer. 96-Well plates were read and recorded on a PerkinElmer
1420 multi-label counter. Automatic pH titration on a Accumet@ Research, AR10 pH meter was
used to determine the pKa values of the sulfhydryl groups on cysteine and homocysteine.
Titration curve was created and analyzed using TitriSoft 2.51.

86

2.2.3.2 Synthesis and Characterization
5-(2-Aminoethylamino)naphthalene-1-sulfonic acid 84 and 5-(N-(2-(dimethylamino)
ethyl)-N-methylamino)naphthalene-1-sulfonic acid 85 was performed following literature
reported procedures.277
5-(N-(2-(Dimethylamino)ethyl)-N-methylamino)naphthalene-1-sulfonyl azide 87: To a
Ar protected solution of 85 (110 mg, 0.36 mmol) in POCl3 (570 µL, 6.2 mmol) was added PCl5
in 2 portions (430 mg, 2.1 mmol). The reaction was stirred on ice bath for 1 h, then warmed to
room temperature, and stirred for additional 2 h. The reaction mixture was poured into 10 g ice.
EtOAc extraction and evaporation gave crude intermediate 5-(N-(2-(dimethylamino)ethyl)-Nmethylamino)naphthalene-1-sulfonyl chloride, which was dissolved in MeOH (2 mL) and added
into a stirred solution of NaN3 (243 mg, 3.75 mmol) in a 1:1 mixed solvent of MeOH/H2O (4
mL). The reaction mixture was stirred at room temperature for 2 h. MeOH was evaporated and
the product was extracted with EtOAc. The organic phase was washed with water and brine, and
dried over Na2SO4. Solvent evaporation followed by flash chromatography (CH2Cl2:Hex:EtOAc,
1:2:0.2) gave a light yellow solid (90 mg, 75% yield). 1H NMR (CDCl3): 8.64 (d, J = 8.4 Hz, 1
H), 8.34 (d, J = 7.2 Hz, 1 H), 8.64 (d, J = 8.8 Hz, 1 H), 7.74-7.64 (m, 2 H), 7.39 (d, J = 7.6 Hz, 1
H), 3.59 (t, J = 7.0 Hz, 2 H), 3.12 (t, J = 7.0 Hz, 2 H), 2.91 (s, 3 H), 2.91 (s, 6 H);

13

C NMR

(CDCl3): 149.8, 134.1, 131.7, 131.0, 130.4, 129.7, 129.2, 124.0, 120.7, 118.3, 60.6, 51.1, 50.4,
45.1; IR 2916.9, 2421.7, 2130.7, 1571.2, 1465.2, 1166.6, 792.6, 743.8; MS (ES+) 333.9 (M+1)+.
5-(N-(2-(Dimethylamino)ethyl)-N-methylamino)naphthalene-1-sulfonyl amide 88:

1

H

NMR (CDCl3): 8.51-8.46 (m, 2 H), 8.26 (d, J = 7.2 Hz, 1 H), 7.65-7.57 (m, 2 H), 7.40-7.38 (m, 1
H), 3.52 (t, J = 6.0 Hz, 2 H), 3.13 (t, J = 6.0 Hz, 2 H), 2.84 (s, 3 H), 2.66 (s, 6 H);

13

C NMR

87

(CDCl3): 149.8, 139.1, 130.6, 129.5, 128.7, 127.5, 127.0, 123.7, 120.8, 117.3, 60.1, 50.2, 49.9,
43.5; MS (ES+) 308.0 (M+1)+.
2.2.4

Conclusions
Hcy is a very important biomarker for the diagnosis and prognosis of various diseases.

However, due to the structural similarity of Hcy and Cys, direct detection of this biomarker still
remains a major challenge. We have developed a novel redox sensitive fluorescent probe for
quantitative Hcy analysis. The sensing reaction is selective for Hcy over other biological thiols
such as Cys and GSH. In addition, a linear calibration curve could be obtained in both buffer and
diluted deproteinized FBS with a detection limit at 10 µM. Endogenous Cys level fluctuation
(200-250 µM) can also be tolerated to provide a good estimation of Hcy concentration. This
probe will be very useful for the selective detection of Hcy in complex biological samples.
2.2.5

Statements
The much of the results in this chapter has been published in Chem. Commun. (Wang,

K.;* Peng, H.;* Dai, C.; Williamson, S.; Wang, B., Redox-based selective fluorometric detection
of homocysteine. Chem. Commun. 2014. 50 (89), 13668-13671, DOI: 10.1039/C4CC03677H)
and J. Cell. Biochem. (Wang, K.; Peng, H.; Wang, B., Recent advances in thiol and sulfide
reactive probes. J. Cell. Biochem. 2014, 115 (6), 1007-1022, DOI: 10.1002/jcb.24762). My
contributions include fluorescence detection and quantitative evaluation of homocysteine probe.
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Appendix A Spectra of compounds and DNA products in DNA modification
Appendix A.1 Spectra of Synthesized Compounds
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Appendix A.2 MALDI-TOF Spectra of DNA Products
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Appendix B Spectra of compounds in hydrogen sulfide probe
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